Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
chromatin assembly (GO:0031497),12/73,8.009744535054569e-15,8.474309718087733e-12,0,0,38.61580912189579,1253.3964709015,H1-5;H1-4;H2BC15;H2BC5;H2BC21;H2BC3;H2BC11;HMGB2;MACROH2A1;H2BC18;H1-3;H1-2
nucleosome organization (GO:0034728),12/94,1.8858217972614794e-13,9.975997307513226e-11,0,0,28.695967157691378,840.7701009933106,H1-5;H1-4;H2BC15;H2BC5;H2BC21;H2BC3;H2BC11;HMGB2;MACROH2A1;H2BC18;H1-3;H1-2
nucleosome assembly (GO:0006334),8/58,1.2241391962916902e-9,4.3171308989220275e-7,0,0,30.227809523809523,620.305723708228,H2BC15;H2BC5;H2BC21;H2BC3;H2BC11;HMGB2;MACROH2A1;H2BC18
protein-DNA complex assembly (GO:0065004),10/143,8.431159003301733e-9,2.2300415563733084e-6,0,0,14.420030659172202,268.08757150561024,H2BC15;MCM7;H2BC5;H2BC21;H2BC3;UBC;H2BC11;HMGB2;MACROH2A1;H2BC18
regulation of RNA splicing (GO:0043484),8/76,1.1070594073986814e-8,2.3425377060556096e-6,0,0,22.206162464985994,406.7941000994136,RBM39;MBNL1;SON;AHNAK;HNRNPH1;TRA2B;SRSF3;SRSF10
"regulation of mRNA splicing, via spliceosome (GO:0048024)",8/90,4.262889269164297e-8,7.516894744626377e-6,0,0,18.401858304297328,312.2930346843218,RBM39;MBNL1;SON;TRA2B;HNRNPU;SRSF3;HNRNPA1;SRSF10
V(D)J recombination (GO:0033151),4/11,3.09178201581561e-7,4.673007675332736e-5,0,0,104.22018348623853,1562.1926012055949,PRKDC;HMGB2;HMGB1;RAG1
negative regulation of chromatin organization (GO:1905268),4/13,6.640694321931913e-7,7.025854592603964e-5,0,0,81.0519877675841,1152.9547289467682,H1-5;H1-4;H1-3;H1-2
negative regulation of chromatin silencing (GO:0031936),4/13,6.640694321931913e-7,7.025854592603964e-5,0,0,81.0519877675841,1152.9547289467682,H1-5;H1-4;H1-3;H1-2
negative regulation of gene silencing (GO:0060969),4/13,6.640694321931913e-7,7.025854592603964e-5,0,0,81.0519877675841,1152.9547289467682,H1-5;H1-4;H1-3;H1-2
"positive regulation of gene expression, epigenetic (GO:0045815)",6/57,8.166514953068104e-7,7.854702563950959e-5,0,0,21.809785596481582,305.7307391214594,H1-5;H1-4;DEK;MACROH2A1;H1-3;H1-2
nucleosome positioning (GO:0016584),4/15,1.2567611885333872e-6,1.1080444478902699e-4,0,0,66.30859049207673,900.933004259897,H1-5;H1-4;H1-3;H1-2
regulation of chromatin silencing (GO:0031935),4/16,1.6683915353655386e-6,1.357814034166723e-4,0,0,60.77981651376147,808.5934392791953,H1-5;H1-4;H1-3;H1-2
chromosome condensation (GO:0030261),5/45,5.373112761463524e-6,4.06053807259172e-4,0,0,22.971064814814813,278.7332701523095,TOP2A;H1-5;H1-4;H1-3;H1-2
mRNA processing (GO:0006397),10/300,7.895960424298882e-6,5.569284085938811e-4,0,0,6.560763307666555,77.08345302120082,SON;HNRNPH1;NONO;TRA2B;HNRNPU;SRSF3;SNRNP200;HNRNPA1;PRPF8;SRSF10
DNA packaging (GO:0006323),4/24,9.407070646501305e-6,6.220425464998988e-4,0,0,36.45321100917431,421.91124878749156,H1-5;H1-4;H1-3;H1-2
"RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",9/251,1.2841330297446584e-5,7.991839679234404e-4,0,0,7.024992053401144,79.12137315564223,HNRNPH1;NONO;TRA2B;HNRNPU;SRSF3;SNRNP200;HNRNPA1;PRPF8;SRSF10
DNA topological change (GO:0006265),3/9,1.4390690582502297e-5,8.458528131270795e-4,0,0,90.36818181818182,1007.5084472670318,TOP2A;HMGB2;HMGB1
"mRNA splicing, via spliceosome (GO:0000398)",9/274,2.5695829688357132e-5,0.001394800045442064,0,0,6.407764876632801,67.7248322214208,HNRNPH1;NONO;TRA2B;HNRNPU;SRSF3;SNRNP200;HNRNPA1;PRPF8;SRSF10
double-strand break repair via nonhomologous end joining (GO:0006303),5/62,2.6366730537657167e-5,0.001394800045442064,0,0,16.106237816764132,169.81462939046625,PRKDC;NSD2;HMGB2;DNTT;HMGB1
DNA metabolic process (GO:0006259),9/277,2.7986938558316463e-5,0.0014100086187951817,0,0,6.335067451205511,66.41540679650127,TOP2A;BTG2;MCM7;PRKDC;UBC;HMGB2;DNTT;HMGB1;RAG1
chromosome organization (GO:0051276),6/106,3.067730950722036e-5,0.0014638195468913344,0,0,11.095514018691588,115.30444055443331,H1-5;TOP2A;UBC;HMGB2;NUCKS1;HMGN2
regulation of RNA metabolic process (GO:0051252),5/65,3.320573641341401e-5,0.0014638195468913344,0,0,15.29861111111111,157.77133175894204,MBNL1;SON;AHNAK;HNRNPH1;TRA2B
mitotic G1 DNA damage checkpoint signaling (GO:0031571),5/65,3.320573641341401e-5,0.0014638195468913344,0,0,15.29861111111111,157.77133175894204,BTG2;CNOT6;TFDP2;PRKDC;SOX4
negative regulation of DNA metabolic process (GO:0051053),4/36,4.949381946932886e-5,0.0020140177307134592,0,0,22.769495412844037,225.72909863335056,H1-5;H1-4;H1-3;H1-2
regulation of mRNA processing (GO:0050684),4/36,4.949381946932886e-5,0.0020140177307134592,0,0,22.769495412844037,225.72909863335056,RBM39;SON;SRSF3;SRSF10
RNA processing (GO:0006396),7/179,7.113758960804593e-5,0.0027875396224189847,0,0,7.569383501535762,72.29438457323438,RBM39;MBNL1;SON;HNRNPH1;NONO;HNRNPU;PRPF8
regulation of DNA recombination (GO:0000018),4/42,9.162548505435042e-5,0.003400514602665802,0,0,19.16851762433607,178.22506432697205,H1-5;H1-4;H1-3;H1-2
positive regulation by host of viral transcription (GO:0043923),3/16,9.320881236040478e-5,0.003400514602665802,0,0,41.69370629370629,386.945457789147,JUN;LEF1;NUCKS1
"positive regulation of transcription, DNA-templated (GO:0045893)",18/1183,1.1033678711304604e-4,0.003891210692186757,0,0,3.0449152925231533,27.74518644614865,H2AZ1;JUN;PRKDC;LEF1;HMGB2;HNRNPU;HMGB1;H1-3;ETV5;H1-2;H1-5;H1-4;TFDP2;CAMK4;MYB;UBC;CD38;SOX4
DNA conformation change (GO:0071103),3/18,1.347042039591539e-4,0.004597324122218866,0,0,36.13090909090909,322.0141715616055,TOP2A;HMGB2;HMGB1
regulation of DNA binding (GO:0051101),4/47,1.4287162050458034e-4,0.0047236929529326874,0,0,16.935353104331128,149.93823408988442,JUN;LEF1;HMGB2;HMGB1
RNA splicing (GO:0008380),5/98,2.3549611994401766e-4,0.007550148330326385,0,0,9.853643966547192,82.31552981306571,MBNL1;NONO;TRA2B;PRPF8;SRSF10
"regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",4/54,2.4573837221964146e-4,0.007646799935540608,0,0,14.559266055045871,121.005599767331,MBNL1;TRA2B;HNRNPU;HNRNPA1
"DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",4/56,2.829323538090045e-4,0.008231263093384374,0,0,13.99788285109386,114.36694035172277,BTG2;CNOT6;TFDP2;SOX4
regulation of apoptotic process (GO:0042981),13/742,2.868845394932873e-4,0.008231263093384374,0,0,3.4163786008230455,27.865455386505264,TOP2A;JUN;PRKDC;LEF1;HMGB1;DUSP6;SOCS2;SON;UBC;PMAIP1;CD38;PPIA;SOX4
"negative regulation of transcription, DNA-templated (GO:0045892)",15/948,2.8786080761363127e-4,0.008231263093384374,0,0,3.1094560010499377,25.35149894817407,JUN;CBX5;NONO;LEF1;HMGB2;HNRNPU;HMGB1;MACROH2A1;ETV5;H1-5;CENPF;TFDP2;MYB;UBC;CD38
negative regulation of DNA recombination (GO:0045910),4/57,3.029690329420111e-4,0.008435295706648624,0,0,13.733079453003288,111.26376119824239,H1-5;H1-4;H1-3;H1-2
positive regulation of gamma-delta T cell activation (GO:0046645),2/5,3.12907902338157e-4,0.0084886297608659,0,0,119.42342342342343,963.699454999233,LEF1;SOX4
apoptotic nuclear changes (GO:0030262),3/24,3.2596951610233536e-4,0.00862189370090677,0,0,25.8,207.1406325983451,TOP2A;HMGB2;HMGB1
double-strand break repair (GO:0006302),6/164,3.400160787217225e-4,0.008774073446038595,0,0,7.001892819117473,55.92074059109156,PRKDC;NSD2;HMGB2;NUCKS1;DNTT;HMGB1
"RNA splicing, via transesterification reactions (GO:0000375)",3/25,3.6889970961037237e-4,0.009292759351613666,0,0,24.626033057851238,194.66844016835708,TRA2B;PRPF8;SRSF10
positive regulation of histone H3-K9 methylation (GO:0051574),2/7,6.52263198553378e-4,0.016048708466731954,0,0,71.64684684684684,525.5340922939538,H1-5;MYB
nucleic acid metabolic process (GO:0090304),4/71,7.013846472748578e-4,0.01649033237370666,0,0,10.855812679720662,78.83984140437856,HNRNPH1;HNRNPU;DNTT;HNRNPA1
myeloid leukocyte differentiation (GO:0002573),4/71,7.013846472748578e-4,0.01649033237370666,0,0,10.855812679720662,78.83984140437856,CAMK4;LEF1;GAB2;DEK
modulation by host of symbiont process (GO:0051851),3/32,7.729864043235797e-4,0.017778687299442333,0,0,18.675235109717867,133.8127115197774,JUN;LEF1;NUCKS1
"DNA damage response, signal transduction by p53 class mediator (GO:0030330)",4/74,8.198813415334122e-4,0.01797510121386201,0,0,10.388990825688074,73.82781465353834,BTG2;CNOT6;TFDP2;SOX4
establishment of protein localization to chromatin (GO:0071169),2/8,8.664746331823843e-4,0.01797510121386201,0,0,59.7027027027027,420.96839710585425,H1-5;MACROH2A1
fusion of virus membrane with host plasma membrane (GO:0019064),2/8,8.664746331823843e-4,0.01797510121386201,0,0,59.7027027027027,420.96839710585425,CXCR4;PPIA
positive regulation of leukocyte differentiation (GO:1902107),2/8,8.664746331823843e-4,0.01797510121386201,0,0,59.7027027027027,420.96839710585425,PRKDC;HMGB1
membrane fusion involved in viral entry into host cell (GO:0039663),2/8,8.664746331823843e-4,0.01797510121386201,0,0,59.7027027027027,420.96839710585425,CXCR4;PPIA
ribonucleoprotein complex assembly (GO:0022618),5/136,0.0010534335621481222,0.021433321322167565,0,0,6.981905569691829,47.86585274154915,RPS27;PRKDC;SNRNP200;SRSF10;EIF3A
negative regulation of cellular macromolecule biosynthetic process (GO:2000113),10/547,0.0010779184208715529,0.021517692250605718,0,0,3.498399956608993,23.903599546000496,JUN;BTG2;CENPF;CBX5;TFDP2;NONO;MYB;LEF1;HMGB2;CD38
T-helper 1 type immune response (GO:0042088),2/9,0.0011099288021481147,0.02174638282727232,0,0,51.171171171171174,348.14098591899386,LEF1;HMGB1
positive regulation of programmed cell death (GO:0043068),7/286,0.0012076658368772694,0.023231099189384565,0,0,4.641103672144451,31.183881156579936,TOP2A;JUN;UBC;PMAIP1;HMGB1;SOX4;DUSP6
chromatin organization (GO:0006325),5/142,0.0012768207329400697,0.02373477152185066,0,0,6.674101108407678,44.4720858139408,H1-5;MYB;HMGB2;NUCKS1;HMGN2
negative regulation of nucleic acid-templated transcription (GO:1903507),9/464,0.0012787164241450733,0.02373477152185066,0,0,3.6958579881656806,24.621430779521425,JUN;CENPF;CBX5;TFDP2;NONO;MYB;LEF1;HMGB2;CD38
regulation of cell cycle G2/M phase transition (GO:1902749),4/85,0.0013757894947207926,0.024787583012886864,0,0,8.973156642881413,59.12168424578754,DYNC1H1;CENPF;TUBB;MACROH2A1
dosage compensation (GO:0007549),2/10,0.0013822943268056002,0.024787583012886864,0,0,44.77252252252252,294.7827630862282,HNRNPU;MACROH2A1
DNA repair (GO:0006281),7/298,0.001528455002797559,0.02695175654933029,0,0,4.4469947481034815,28.83208091436969,BTG2;PRKDC;UBC;NSD2;USP1;HUWE1;NUCKS1
nucleus localization (GO:0051647),2/11,0.001683242577714899,0.029194600774137103,0,0,39.7957957957958,254.1770705617978,DYNC1H1;SYNE2
cellular glucose homeostasis (GO:0001678),3/43,0.0018384652062925309,0.031372519165443515,0,0,13.532045454545454,85.23597514715335,TRA2B;NUCKS1;SOX4
positive regulation of apoptotic process (GO:0043065),7/310,0.0019122252866522731,0.03211324370282707,0,0,4.268260788342985,26.717125664069375,TOP2A;JUN;UBC;PMAIP1;HMGB1;SOX4;DUSP6
regulation of histone H3-K9 methylation (GO:0051570),2/12,0.002012447655534119,0.0332682753055484,0,0,35.814414414414415,222.35033790257316,H1-5;MYB
protein modification by small protein conjugation (GO:0032446),8/409,0.0022587224047138452,0.03633365769683812,0,0,3.7023631397696235,22.558335459295492,NUP214;H2BC15;H2BC5;PRKDC;H2BC3;UBC;H2BC11;HUWE1
entry into host (GO:0044409),2/13,0.0023695863715329207,0.03633365769683812,0,0,32.55692055692056,196.8078826757668,CXCR4;PPIA
establishment of protein localization to chromosome (GO:0070199),2/13,0.0023695863715329207,0.03633365769683812,0,0,32.55692055692056,196.8078826757668,H1-5;MACROH2A1
spliceosomal tri-snRNP complex assembly (GO:0000244),2/13,0.0023695863715329207,0.03633365769683812,0,0,32.55692055692056,196.8078826757668,PRPF8;SRSF10
positive regulation of vascular endothelial cell proliferation (GO:1905564),2/13,0.0023695863715329207,0.03633365769683812,0,0,32.55692055692056,196.8078826757668,HMGB1;FGFR1
mitotic cytokinesis (GO:0000281),3/49,0.0026781109781815046,0.039379592513867814,0,0,11.763438735177866,69.6706550433352,SON;STMN1;SPTBN1
regulation of chromatin organization (GO:1902275),2/14,0.0027543382287582405,0.039379592513867814,0,0,29.84234234234234,175.90801680556538,HNRNPU;MKI67
nuclear migration (GO:0007097),2/14,0.0027543382287582405,0.039379592513867814,0,0,29.84234234234234,175.90801680556538,DYNC1H1;SYNE2
T-helper cell differentiation (GO:0042093),2/14,0.0027543382287582405,0.039379592513867814,0,0,29.84234234234234,175.90801680556538,LEF1;HMGB1
myeloid dendritic cell activation (GO:0001773),2/14,0.0027543382287582405,0.039379592513867814,0,0,29.84234234234234,175.90801680556538,CAMK4;HMGB1
regulation of gene expression (GO:0010468),14/1079,0.0030508961915197445,0.043037975608371866,0,0,2.499245980936122,14.476432225968148,MBNL1;AHNAK;NONO;LEF1;MACROH2A1;ACTG1;SON;HNRNPH1;TRA2B;MYB;NSD2;SRSF10;SOX4;RAG1
apoptotic DNA fragmentation (GO:0006309),2/16,0.0036054127233747734,0.04953930729000663,0,0,25.576576576576578,143.876402898192,HMGB2;HMGB1
dendritic cell chemotaxis (GO:0002407),2/16,0.0036054127233747734,0.04953930729000663,0,0,25.576576576576578,143.876402898192,CXCR4;HMGB1
interstrand cross-link repair (GO:0036297),3/55,0.0037211855876421716,0.050474542970838684,0,0,10.402972027972028,58.19123940459462,UBC;USP1;NUCKS1
positive regulation of establishment of protein localization to mitochondrion (GO:1903749),3/56,0.003915804437813117,0.052442039179826296,0,0,10.206174957118353,56.57011799511348,TFDP2;HUWE1;PMAIP1
regulation of cell population proliferation (GO:0042127),11/764,0.003984003896230632,0.05245949407767596,0,0,2.7403327865010545,15.141621015086118,DPP4;JUN;CNOT6;BTG2;H2AC6;PRKDC;LEF1;HMGB2;GAB2;SOX4;FGFR1
regulation of stem cell proliferation (GO:0072091),2/17,0.004071107650863602,0.05245949407767596,0,0,23.87027027027027,131.3781522978749,HMGB2;HNRNPU
ribosomal small subunit assembly (GO:0000028),2/17,0.004071107650863602,0.05245949407767596,0,0,23.87027027027027,131.3781522978749,RPS27;PRKDC
gene expression (GO:0010467),7/356,0.004115442352029399,0.05245949407767596,0,0,3.6969778883062117,20.307532640156165,NUP214;RBM39;RPS27;RPL21;HNRNPH1;HNRNPU;SRSF3
dendritic cell migration (GO:0036336),2/18,0.004563160265358056,0.056797924244103806,0,0,22.37725225225225,120.60756830597164,CXCR4;HMGB1
regulation of vascular endothelial cell proliferation (GO:1905562),2/18,0.004563160265358056,0.056797924244103806,0,0,22.37725225225225,120.60756830597164,HMGB1;FGFR1
negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),2/19,0.005081263238737216,0.0617928334090112,0,0,21.05988341282459,111.24241885101868,NONO;PPIA
regulation of histone H3-K4 methylation (GO:0051569),2/19,0.005081263238737216,0.0617928334090112,0,0,21.05988341282459,111.24241885101868,MYB;MACROH2A1
positive regulation of transcription by RNA polymerase II (GO:0045944),12/908,0.005245781953541791,0.06306860575962744,0,0,2.5182549504950495,13.221671938627328,H2AZ1;JUN;TFDP2;PRKDC;MYB;UBC;LEF1;HMGB2;HNRNPU;HMGB1;SOX4;ETV5
negative regulation of telomere maintenance via telomerase (GO:0032211),2/20,0.005625111821885011,0.06612631452838158,0,0,19.88888888888889,103.03467631601124,HNRNPU;HNRNPA1
granulocyte differentiation (GO:0030851),2/20,0.005625111821885011,0.06612631452838158,0,0,19.88888888888889,103.03467631601124,LEF1;DEK
antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),3/64,0.005696722479021683,0.06623222398686748,0,0,8.86408345752608,45.80838021481263,H2BC21;H2BC11;HMGN2
microtubule cytoskeleton organization involved in mitosis (GO:1902850),4/128,0.0060243423986577746,0.06756370356242129,0,0,5.848771825984019,29.898611303010963,DYNC1H1;CENPF;RPS27;STMN1
regulation of cell-substrate junction assembly (GO:0090109),2/21,0.0061944038237758655,0.06756370356242129,0,0,18.841156946420103,95.79049566946637,MACF1;ACTG1
histone ubiquitination (GO:0016574),2/21,0.0061944038237758655,0.06756370356242129,0,0,18.841156946420103,95.79049566946637,HUWE1;RAG1
innate immune response in mucosa (GO:0002227),2/21,0.0061944038237758655,0.06756370356242129,0,0,18.841156946420103,95.79049566946637,H2BC21;H2BC11
stress granule assembly (GO:0034063),2/21,0.0061944038237758655,0.06756370356242129,0,0,18.841156946420103,95.79049566946637,DYNC1H1;CSDE1
protein localization to chromatin (GO:0071168),2/21,0.0061944038237758655,0.06756370356242129,0,0,18.841156946420103,95.79049566946637,H1-5;MACROH2A1
RNA metabolic process (GO:0016070),4/133,0.006885737441145267,0.0743378593135887,0,0,5.620652869639428,27.98131329111859,RBM39;HNRNPH1;HNRNPU;HNRNPA1
cell chemotaxis (GO:0060326),3/69,0.007019532049551451,0.07501681725682258,0,0,8.190495867768595,40.6171499769049,LEF1;HMGB2;CXCR4
defense response to Gram-positive bacterium (GO:0050830),3/70,0.007304075851125718,0.07684110857075364,0,0,8.067842605156038,39.68832167797083,H2BC21;H2BC11;HMGB2
cytoskeleton-dependent intracellular transport (GO:0030705),2/23,0.007408121998314624,0.07684110857075364,0,0,17.045045045045047,83.60898530449813,TUBA1B;TUBB
"DNA catabolic process, endonucleolytic (GO:0000737)",2/23,0.007408121998314624,0.07684110857075364,0,0,17.045045045045047,83.60898530449813,HMGB2;HMGB1
cytoskeleton-dependent cytokinesis (GO:0061640),3/72,0.007893457015040095,0.08108036429041185,0,0,7.833201581027668,37.926177286289274,SON;STMN1;SPTBN1
cellular response to hexose stimulus (GO:0071331),2/25,0.008720050690488033,0.0878648917193937,0,0,15.561300430865648,73.79371315940043,TRA2B;SOX4
regulation of spindle assembly (GO:0090169),2/25,0.008720050690488033,0.0878648917193937,0,0,15.561300430865648,73.79371315940043,DYNC1H1;HNRNPU
fibroblast growth factor receptor signaling pathway (GO:0008543),3/75,0.008828793596810975,0.08812135495684917,0,0,7.505681818181818,35.49990024913238,HNRNPH1;HNRNPA1;FGFR1
RNA transport (GO:0050658),3/76,0.009154375868503381,0.08882435803064499,0,0,7.402490660024907,34.74376222074018,NUP214;SRSF3;HNRNPA1
negative regulation of telomere maintenance via telomere lengthening (GO:1904357),2/26,0.009412115154388159,0.08882435803064499,0,0,14.912162162162161,69.57653354304188,HNRNPU;HNRNPA1
DNA geometric change (GO:0032392),2/26,0.009412115154388159,0.08882435803064499,0,0,14.912162162162161,69.57653354304188,HMGB2;HMGB1
regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),2/26,0.009412115154388159,0.08882435803064499,0,0,14.912162162162161,69.57653354304188,TFDP2;PMAIP1
positive regulation of histone methylation (GO:0031062),2/26,0.009412115154388159,0.08882435803064499,0,0,14.912162162162161,69.57653354304188,H1-5;MYB
positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),2/26,0.009412115154388159,0.08882435803064499,0,0,14.912162162162161,69.57653354304188,TFDP2;PMAIP1
positive regulation of endothelial cell proliferation (GO:0001938),3/77,0.00948691158550367,0.08882435803064499,0,0,7.302088452088452,34.01197543472876,HMGB2;HMGB1;FGFR1
protein ubiquitination (GO:0016567),8/525,0.009893024243532637,0.09181420745313623,0,0,2.8545638758404714,13.17645387777677,H2BC15;H2BC5;PRKDC;H2BC3;UBC;H2BC11;HUWE1;RAG1
positive regulation of erythrocyte differentiation (GO:0045648),2/27,0.010127862575858215,0.09317633569789557,0,0,14.314954954954954,65.74092935536063,PRKDC;HMGB2
mucosal immune response (GO:0002385),2/28,0.01086700815402934,0.09911460885312968,0,0,13.763686763686763,62.239719871999625,H2BC21;H2BC11
aggrephagy (GO:0035973),2/29,0.011629269499553745,0.1042692129705751,0,0,13.253253253253254,59.03303991022321,DYNC1H1;UBC
positive regulation of viral genome replication (GO:0045070),2/29,0.011629269499553745,0.1042692129705751,0,0,13.253253253253254,59.03303991022321,TOP2A;PPIA
nuclear export (GO:0051168),3/84,0.012011667047540432,0.10679280450670402,0,0,6.668686868686868,29.48811206830847,NUP214;SRSF3;HNRNPA1
mitotic spindle organization (GO:0007052),4/157,0.012151628220897933,0.10713685548091677,0,0,4.733225400251844,20.8749066291745,DYNC1H1;CENPF;RPS27;STMN1
Golgi to plasma membrane protein transport (GO:0043001),2/30,0.01241436662066965,0.10854875937742554,0,0,12.77927927927928,56.08699005654072,MACF1;SPTBN1
negative regulation of phosphorylation (GO:0042326),3/86,0.012797079305414915,0.11097795004204082,0,0,6.507338444687842,28.3624839291586,PRKDC;HNRNPU;PPIA
negative regulation of DNA binding (GO:0043392),2/31,0.01322202189727877,0.11373088753919464,0,0,12.337993165579373,53.37257317425967,JUN;LEF1
negative regulation of DNA biosynthetic process (GO:2000279),2/32,0.014051960075864917,0.11893579008212067,0,0,11.926126126126126,50.86484904559121,HNRNPU;HNRNPA1
cellular response to glucose stimulus (GO:0071333),2/32,0.014051960075864917,0.11893579008212067,0,0,11.926126126126126,50.86484904559121,TRA2B;SOX4
positive regulation of binding (GO:0051099),3/90,0.014454374839418884,0.12137086174686651,0,0,6.206896551724138,26.297119571537507,STMN1;HMGB2;HMGB1
regulation of stem cell differentiation (GO:2000736),3/91,0.014886811622751005,0.12401769052653987,0,0,6.136053719008265,25.816093538162875,PRKDC;MYB;HNRNPU
cellular response to fibroblast growth factor stimulus (GO:0044344),3/92,0.015326523161880453,0.12668329300991812,0,0,6.066802860061287,25.34813620193396,HNRNPH1;HNRNPA1;FGFR1
negative regulation of transcription by RNA polymerase II (GO:0000122),9/684,0.015501250324254442,0.12713428560512557,0,0,2.463076923076923,10.263234126398721,H1-5;JUN;CBX5;MYB;UBC;HNRNPU;HMGB1;MACROH2A1;ETV5
positive regulation of DNA binding (GO:0043388),2/34,0.015777595788599556,0.12742516293388037,0,0,11.179617117117116,46.38606860239311,HMGB2;HMGB1
positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),2/34,0.015777595788599556,0.12742516293388037,0,0,11.179617117117116,46.38606860239311,TFDP2;PMAIP1
nuclear-transcribed mRNA catabolic process (GO:0000956),4/171,0.01616208771658239,0.12954158184957704,0,0,4.333351645333186,17.875452728614224,CNOT6;RPS27;RPL21;CSDE1
regulation of mitotic spindle organization (GO:0060236),2/35,0.016672754449740836,0.13177178559795985,0,0,10.84029484029484,44.37994335341846,DYNC1H1;HNRNPU
mRNA metabolic process (GO:0016071),3/95,0.01668943220238811,0.13177178559795985,0,0,5.868083003952569,24.017943803975125,SON;NONO;PRPF8
platelet aggregation (GO:0070527),2/36,0.017589118223361625,0.13683299323762205,0,0,10.520932697403286,42.50956397205026,PPIA;ACTG1
establishment of protein localization to plasma membrane (GO:0061951),2/36,0.017589118223361625,0.13683299323762205,0,0,10.520932697403286,42.50956397205026,MACF1;SPTBN1
positive regulation of cell population proliferation (GO:0008284),7/474,0.018089766290186566,0.13970053091253568,0,0,2.7461516706395703,11.018683401114536,DPP4;CNOT6;LEF1;HNRNPU;GAB2;SOX4;FGFR1
regulation of translation (GO:0006417),4/178,0.018444820310882626,0.1400068281869786,0,0,4.1575450806706735,16.600959806470392,BTG2;PRKDC;CSDE1;SOX4
regulation of erythrocyte differentiation (GO:0045646),2/37,0.01852642338958129,0.1400068281869786,0,0,10.21981981981982,40.762336687515074,PRKDC;HMGB2
positive regulation of myeloid cell differentiation (GO:0045639),2/37,0.01852642338958129,0.1400068281869786,0,0,10.21981981981982,40.762336687515074,PRKDC;HMGB2
negative regulation of G0 to G1 transition (GO:0070317),2/38,0.019484408486336,0.14410206643941478,0,0,9.935435435435435,39.12714264101864,CBX5;TFDP2
response to estradiol (GO:0032355),2/38,0.019484408486336,0.14410206643941478,0,0,9.935435435435435,39.12714264101864,SOCS2;H2AZ1
spliceosomal snRNP assembly (GO:0000387),2/38,0.019484408486336,0.14410206643941478,0,0,9.935435435435435,39.12714264101864,PRPF8;SRSF10
positive regulation of protein localization to membrane (GO:1905477),3/101,0.019613135696857967,0.14410206643941478,0,0,5.507142857142857,21.651639158397582,TFDP2;PMAIP1;SPTBN1
protein monoubiquitination (GO:0006513),2/39,0.020462814286818932,0.14727658173778524,0,0,9.666423179936693,37.594130824574165,HUWE1;RAG1
regulation of intracellular transport (GO:0032386),2/39,0.020462814286818932,0.14727658173778524,0,0,9.666423179936693,37.594130824574165,NUP214;DYNC1H1
DNA recombination (GO:0006310),2/39,0.020462814286818932,0.14727658173778524,0,0,9.666423179936693,37.594130824574165,HMGB1;RAG1
negative regulation of programmed cell death (GO:0043069),6/381,0.0211608940318214,0.1512717965247773,0,0,2.9176822429906544,11.24941688690874,SOCS2;SON;PRKDC;UBC;LEF1;CD38
regulation of mitotic cell cycle phase transition (GO:1901990),4/188,0.022038285132398323,0.1531367626943919,0,0,3.929597128041484,14.991311285713868,DYNC1H1;CENPF;TUBB;UBC
RNA export from nucleus (GO:0006405),3/106,0.022251956816735065,0.1531367626943919,0,0,5.238481906443072,19.93412787580576,NUP214;SRSF3;HNRNPA1
regulation of G0 to G1 transition (GO:0070316),2/41,0.02247986220328451,0.1531367626943919,0,0,9.16978516978517,34.80057615898612,CBX5;TFDP2
T cell differentiation (GO:0030217),2/41,0.02247986220328451,0.1531367626943919,0,0,9.16978516978517,34.80057615898612,SOX4;RAG1
cellular response to glucose starvation (GO:0042149),2/43,0.024575537517548953,0.1531367626943919,0,0,8.721599648428917,32.32228092155592,PMAIP1;HNRNPA1
positive regulation of T cell differentiation (GO:0045582),2/43,0.024575537517548953,0.1531367626943919,0,0,8.721599648428917,32.32228092155592,LEF1;SOX4
positive regulation of cellular process (GO:0048522),8/625,0.025431150255021972,0.1531367626943919,0,0,2.3795631704869953,8.737233572632784,DPP4;H1-5;DYNC1H1;CNOT6;LEF1;GAB2;SOX4;FGFR1
antibacterial humoral response (GO:0019731),2/44,0.02565223571842216,0.1531367626943919,0,0,8.513513513513514,31.186060346633635,H2BC21;H2BC11
homotypic cell-cell adhesion (GO:0034109),2/44,0.02565223571842216,0.1531367626943919,0,0,8.513513513513514,31.186060346633635,PPIA;ACTG1
positive regulation of nucleic acid-templated transcription (GO:1903508),7/511,0.02596898782610329,0.1531367626943919,0,0,2.539701257861635,9.272073997758243,JUN;CAMK4;MYB;LEF1;HMGB2;CD38;SOX4
regulation of DNA repair (GO:0006282),2/45,0.026747845393941712,0.1531367626943919,0,0,8.315105803477897,30.11150391231291,USP1;DEK
transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),6/404,0.027205194306292497,0.1531367626943919,0,0,2.7458319635560984,9.896932179975208,SOCS2;HNRNPH1;STMN1;HNRNPA1;ACTG1;FGFR1
regulation of DNA metabolic process (GO:0051052),2/46,0.027862122543358334,0.1531367626943919,0,0,8.125716625716626,29.094023779947253,USP1;NUCKS1
positive regulation of organelle assembly (GO:1902117),2/46,0.027862122543358334,0.1531367626943919,0,0,8.125716625716626,29.094023779947253,DYNC1H1;CNOT6
spliceosomal complex assembly (GO:0000245),2/46,0.027862122543358334,0.1531367626943919,0,0,8.125716625716626,29.094023779947253,SNRNP200;SRSF10
"negative regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043371)",1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,HMGB1
apoptotic chromosome condensation (GO:0030263),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,TOP2A
negative regulation of histone H3-K27 methylation (GO:0061086),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,MACROH2A1
negative regulation of interleukin-13 production (GO:0032696),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,LEF1
negative regulation of interleukin-5 production (GO:0032714),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,LEF1
"CD4-positive, alpha-beta T cell activation (GO:0035710)",1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,HMGB1
negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,NONO
regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,HNRNPU
negative regulation of protein polyubiquitination (GO:1902915),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,PPIA
regulation of guanyl-nucleotide exchange factor activity (GO:1905097),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,STMN1
regulation of heart growth (GO:0060420),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,DUSP6
negative regulation of transcription by RNA polymerase I (GO:0016479),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,MACROH2A1
cellular response to sodium arsenite (GO:1903936),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,HNRNPA1
chemokine (C-X-C motif) ligand 12 signaling pathway (GO:0038146),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,CXCR4
regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,MACROH2A1
CRD-mediated mRNA stabilization (GO:0070934),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,HNRNPU
regulation of metaphase plate congression (GO:0090235),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,DYNC1H1
positive regulation by host of viral genome replication (GO:0044829),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,NUCKS1
positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,HNRNPU
positive regulation of dendritic cell differentiation (GO:2001200),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,HMGB1
positive regulation of DNA ligation (GO:0051106),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,HMGB1
positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,HNRNPU
response to sodium arsenite (GO:1903935),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,HNRNPA1
positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,MACROH2A1
positive regulation of maintenance of sister chromatid cohesion (GO:0034093),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,MACROH2A1
positive regulation of mast cell activation involved in immune response (GO:0033008),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,GAB2
kidney morphogenesis (GO:0060993),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,SOX4
spliceosomal conformational changes to generate catalytic conformation (GO:0000393),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,SNRNP200
tight junction organization (GO:0120193),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,ACTG1
positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),1/5,0.027935156143683967,0.1531367626943919,0,0,44.38169642857143,158.79190942444083,HMGB1
epithelial to mesenchymal transition (GO:0001837),2/47,0.028994825266323607,0.15812641820500195,0,0,7.944744744744745,28.1294643809283,LEF1;FGFR1
positive regulation of blood vessel endothelial cell migration (GO:0043536),2/48,0.030145713774935485,0.1627253325198048,0,0,7.771641206423815,27.21405338550327,HMGB1;FGFR1
Golgi to plasma membrane transport (GO:0006893),2/48,0.030145713774935485,0.1627253325198048,0,0,7.771641206423815,27.21405338550327,MACF1;SPTBN1
response to glucose (GO:0009749),2/49,0.03131455034104185,0.16433190990763913,0,0,7.605903776116542,26.344359156210242,TRA2B;SOX4
cellular response to organic substance (GO:0071310),3/123,0.03260076923530409,0.16433190990763913,0,0,4.4925,15.379711630747648,SOCS2;LEF1;CXCR4
negative regulation of hematopoietic progenitor cell differentiation (GO:1901533),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,MYB
cardiac ventricle formation (GO:0003211),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,SOX4
negative regulation of T cell differentiation in thymus (GO:0033085),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,TMEM131L
cellular response to salt (GO:1902075),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,HNRNPA1
cellular response to X-ray (GO:0071481),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,NUCKS1
regulation of immature T cell proliferation in thymus (GO:0033084),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,TMEM131L
neuroepithelial cell differentiation (GO:0060563),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,SOX4
regulation of nuclease activity (GO:0032069),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,HMGB2
positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,HUWE1
regulation of T-helper cell differentiation (GO:0045622),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,MYB
positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902237),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,PMAIP1
positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,PMAIP1
positive regulation of granulocyte differentiation (GO:0030854),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,LEF1
spinal cord motor neuron differentiation (GO:0021522),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,SOX4
monoubiquitinated protein deubiquitination (GO:0035520),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,USP1
protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),1/6,0.03342867805356121,0.16433190990763913,0,0,35.503571428571426,120.65324680080013,PMAIP1
DNA duplex unwinding (GO:0032508),2/51,0.03370512707935509,0.16433190990763913,0,0,7.294723294723295,24.72988020809944,MCM7;UBC
inositol lipid-mediated signaling (GO:0048017),2/51,0.03370512707935509,0.16433190990763913,0,0,7.294723294723295,24.72988020809944,GAB2;FGFR1
mesenchymal cell differentiation (GO:0048762),2/51,0.03370512707935509,0.16433190990763913,0,0,7.294723294723295,24.72988020809944,LEF1;FGFR1
cellular response to oxidative stress (GO:0034599),3/125,0.033957362555601965,0.16480224579737102,0,0,4.418405365126676,14.945917069482947,JUN;PPIA;ETV5
regulation of telomere maintenance via telomerase (GO:0032210),2/52,0.03492640206272318,0.16873120265918323,0,0,7.148468468468469,23.979624900995343,HNRNPU;HNRNPA1
plasma membrane bounded cell projection organization (GO:0120036),3/128,0.036046614326873005,0.17144638187530148,0,0,4.3117090909090905,14.327560677397376,BTG2;STMN1;HMGB1
regulation of focal adhesion assembly (GO:0051893),2/54,0.03741977747531487,0.17144638187530148,0,0,6.872834372834373,22.58108155659642,MACF1;ACTG1
regulation of blood vessel endothelial cell migration (GO:0043535),2/55,0.03869142477617919,0.17144638187530148,0,0,6.742818289988102,21.928570770290403,HMGB1;FGFR1
negative regulation of cell cycle phase transition (GO:1901988),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,MACROH2A1
regulation of cytoplasmic mRNA processing body assembly (GO:0010603),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,CNOT6
regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,FGFR1
negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,PPIA
regulation of histone H3-K27 methylation (GO:0061085),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,MACROH2A1
noradrenergic neuron differentiation (GO:0003357),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,SOX4
regulation of muscle organ development (GO:0048634),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,CENPF
DNA ligation (GO:0006266),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,TOP2A
regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,NONO
regulation of T cell mediated immune response to tumor cell (GO:0002840),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,HMGB1
positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,HMGB1
response to host defenses (GO:0052200),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,UBC
positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,HUWE1
somatic recombination of immunoglobulin gene segments (GO:0016447),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,PRKDC
lymphoid progenitor cell differentiation (GO:0002320),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,SOX4
membrane biogenesis (GO:0044091),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,SPTBN1
mitral valve development (GO:0003174),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,SOX4
modulation by symbiont of host defense response (GO:0052031),1/7,0.038891428780786726,0.17144638187530148,0,0,29.584821428571427,96.0613646778723,UBC
chordate embryonic development (GO:0043009),2/58,0.042603527751110044,0.18176103232128835,0,0,6.38063063063063,20.13611038696133,MBNL1;FGFR1
selective autophagy (GO:0061912),2/59,0.043939216777844,0.18176103232128835,0,0,6.268373636794689,19.588341891450526,DYNC1H1;UBC
regulation of cellular component organization (GO:0051128),3/139,0.04425926655857882,0.18176103232128835,0,0,3.9607620320855617,12.34843022237387,SOCS2;HNRNPU;MKI67
negative regulation of chromosome organization (GO:2001251),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,TOP2A
antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,ERAP2
regulation of apoptotic cell clearance (GO:2000425),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,HMGB1
negative regulation of mitochondrial fusion (GO:0010637),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,HUWE1
negative regulation of mitochondrial membrane potential (GO:0010917),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,PMAIP1
regulation of endodeoxyribonuclease activity (GO:0032071),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,HMGB1
regulation of myeloid leukocyte differentiation (GO:0002761),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,CAMK4
"positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,MYB
regulation of striated muscle tissue development (GO:0016202),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,CENPF
positive regulation of dendritic cell cytokine production (GO:0002732),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,CAMK4
positive regulation of isomerase activity (GO:0010912),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,HNRNPU
positive regulation of oligodendrocyte differentiation (GO:0048714),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,CXCR4
pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,MCM7
protein localization to microtubule (GO:0035372),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,HNRNPU
negative regulation of alpha-beta T cell differentiation (GO:0046639),1/8,0.044323578770219654,0.18176103232128835,0,0,25.357142857142858,79.01890460278796,HMGB1
response to organic cyclic compound (GO:0014070),2/60,0.0452903718026147,0.1850085458191751,0,0,6.159987573780677,19.063072147431072,SOCS2;PMAIP1
"regulation of DNA-templated transcription, initiation (GO:2000142)",2/61,0.04665677887186548,0.18912977795568456,0,0,6.055275614597648,18.55903857192474,JUN;LEF1
pattern recognition receptor signaling pathway (GO:0002221),2/61,0.04665677887186548,0.18912977795568456,0,0,6.055275614597648,18.55903857192474,UBC;HMGB1
neuron development (GO:0048666),3/143,0.047457649099598105,0.19164195705104883,0,0,3.8468181818181817,11.724784700164676,BTG2;STMN1;HMGB1
negative regulation of kinase activity (GO:0033673),2/62,0.04803822593505056,0.19251682969425568,0,0,5.954054054054054,18.07506848550326,HNRNPU;PPIA
positive regulation of cysteine-type endopeptidase activity (GO:2001056),2/62,0.04803822593505056,0.19251682969425568,0,0,5.954054054054054,18.07506848550326,PMAIP1;HMGB1
membrane organization (GO:0061024),4/242,0.04852697775002036,0.19270829643099044,0,0,3.029681597409606,9.166711871902491,UBC;HUWE1;SPTBN1;ACTG1
cellular response to DNA damage stimulus (GO:0006974),5/350,0.04857143081024955,0.19270829643099044,0,0,2.6223832528180355,7.93197445445686,TOP2A;BTG2;CBX5;MCM7;PRKDC
regulation of cellular macromolecule biosynthetic process (GO:2000112),6/468,0.04971910680943559,0.19270829643099044,0,0,2.3576890399320307,7.076287668592635,NONO;MYB;NSD2;NUCKS1;SRSF10;SOX4
axon regeneration (GO:0031103),1/9,0.049725297661304714,0.19270829643099044,0,0,22.186383928571427,66.58669547384002,NREP
negative regulation of membrane potential (GO:0045837),1/9,0.049725297661304714,0.19270829643099044,0,0,22.186383928571427,66.58669547384002,PMAIP1
positive regulation of mast cell degranulation (GO:0043306),1/9,0.049725297661304714,0.19270829643099044,0,0,22.186383928571427,66.58669547384002,GAB2
positive regulation of megakaryocyte differentiation (GO:0045654),1/9,0.049725297661304714,0.19270829643099044,0,0,22.186383928571427,66.58669547384002,HMGB2
kinetochore assembly (GO:0051382),1/9,0.049725297661304714,0.19270829643099044,0,0,22.186383928571427,66.58669547384002,CENPF
mitral valve morphogenesis (GO:0003183),1/9,0.049725297661304714,0.19270829643099044,0,0,22.186383928571427,66.58669547384002,SOX4
regulation of mRNA stability (GO:0043488),3/146,0.049929368639479096,0.19279296357871856,0,0,3.7655435473617294,11.285883402224052,NUP214;UBC;HNRNPU
negative regulation of cell cycle process (GO:0010948),2/64,0.05084540110377363,0.1942037341797563,0,0,5.761406567858181,17.163031979109387,CBX5;TFDP2
plasma membrane organization (GO:0007009),2/64,0.05084540110377363,0.1942037341797563,0,0,5.761406567858181,17.163031979109387,CXCR4;SPTBN1
pre-replicative complex assembly (GO:0036388),2/64,0.05084540110377363,0.1942037341797563,0,0,5.761406567858181,17.163031979109387,MCM7;UBC
positive regulation of intracellular protein transport (GO:0090316),3/148,0.05161157923857481,0.19561196632406347,0,0,3.713228840125392,11.006044547142912,TFDP2;HUWE1;PMAIP1
regulation of cell-matrix adhesion (GO:0001952),2/65,0.05227071437892858,0.19561196632406347,0,0,5.66966966966967,16.73300392900706,MACF1;ACTG1
regulation of G2/M transition of mitotic cell cycle (GO:0010389),3/149,0.05246293425384142,0.19561196632406347,0,0,3.68760896637609,10.869774569786674,DYNC1H1;CENPF;TUBB
brain development (GO:0007420),3/150,0.05332109057403281,0.19561196632406347,0,0,3.6623376623376624,10.73586206756134,CENPF;UGP2;CXCR4
negative regulation of protein phosphorylation (GO:0001933),3/152,0.055057709304336434,0.19561196632406347,0,0,3.6128126906650397,10.474892955822476,PRKDC;PPIA;MACROH2A1
negative regulation of extracellular matrix organization (GO:1903054),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,DPP4
regulation of cell-cell adhesion mediated by integrin (GO:0033632),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,DPP4
cellular response to interleukin-4 (GO:0071353),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,LEF1
regulation of granulocyte differentiation (GO:0030852),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,LEF1
negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,JUN
regulation of histone phosphorylation (GO:0033127),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,MACROH2A1
neuron projection regeneration (GO:0031102),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,NREP
regulation of organ growth (GO:0046620),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,DUSP6
regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,HMGB1
response to interleukin-4 (GO:0070670),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,LEF1
positive regulation of lipase activity (GO:0060193),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,FGFR1
sequestering of actin monomers (GO:0042989),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,TMSB10
modification-dependent macromolecule catabolic process (GO:0043632),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,UBC
modulation by symbiont of host process (GO:0044003),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,UBC
myelin maintenance (GO:0043217),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,CXCR4
myeloid dendritic cell differentiation (GO:0043011),1/10,0.055096754219821284,0.19561196632406347,0,0,19.720238095238095,57.16235353894127,CAMK4
cellular response to cytokine stimulus (GO:0071345),6/482,0.05582537339349906,0.19687748350107334,0,0,2.2866959868059373,6.598322536539966,SOCS2;UBC;LEF1;HNRNPU;CXCR4;GAB2
positive regulation of gene expression (GO:0010628),6/482,0.05582537339349906,0.19687748350107334,0,0,2.2866959868059373,6.598322536539966,PRKDC;LEF1;DEK;MACROH2A1;SOX4;ACTG1
negative regulation of apoptotic process (GO:0043066),6/485,0.05719053684271416,0.20102188697538734,0,0,2.2720231010867655,6.501091547749046,SOCS2;SON;PRKDC;UBC;LEF1;CD38
kidney development (GO:0001822),2/70,0.059606405298078216,0.20299532406228038,0,0,5.251457339692633,14.809068942639515,CENPF;SOX4
atrial septum morphogenesis (GO:0060413),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,SOX4
cell differentiation in spinal cord (GO:0021515),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,SOX4
negative regulation of oxidative stress-induced neuron death (GO:1903204),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,NONO
cellular glucan metabolic process (GO:0006073),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,UGP2
columnar/cuboidal epithelial cell differentiation (GO:0002065),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,SOX4
nuclear DNA replication (GO:0033260),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,MCM7
regulation of mitochondrial fusion (GO:0010635),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,HUWE1
regulation of phospholipase activity (GO:0010517),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,FGFR1
positive regulation by host of viral process (GO:0044794),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,NUCKS1
regulation of T cell mediated immunity (GO:0002709),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,HMGB1
regulation of toll-like receptor 9 signaling pathway (GO:0034163),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,HMGB1
hepatocyte growth factor receptor signaling pathway (GO:0048012),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,STMN1
T cell homeostasis (GO:0043029),1/11,0.06043811633234245,0.20299532406228038,0,0,17.74732142857143,49.80138528268159,PMAIP1
regulation of hematopoietic stem cell differentiation (GO:1902036),2/71,0.0611139735177439,0.20397029647247017,0,0,5.175088131609871,14.464447607652474,PRKDC;MYB
phosphatidylinositol-mediated signaling (GO:0048015),2/71,0.0611139735177439,0.20397029647247017,0,0,5.175088131609871,14.464447607652474,GAB2;FGFR1
positive regulation of protein secretion (GO:0050714),2/72,0.06263456172564622,0.20765082079371136,0,0,5.100900900900901,14.131729939962863,PPIA;SOX4
defense response to Gram-negative bacterium (GO:0050829),2/73,0.06416797767577442,0.20765082079371136,0,0,5.028803451338662,13.810356420649189,H2BC11;HMGB2
proteolysis involved in cellular protein catabolic process (GO:0051603),2/74,0.0657140308541901,0.20765082079371136,0,0,4.958708708708708,13.499800904963,UBC;PMAIP1
regulation of stress fiber assembly (GO:0051492),2/74,0.0657140308541901,0.20765082079371136,0,0,4.958708708708708,13.499800904963,STMN1;ACTG1
"regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,HMGB1
negative regulation of microtubule polymerization (GO:0031115),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,STMN1
regulation of dendritic cell differentiation (GO:2001198),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,HMGB1
cellular response to growth hormone stimulus (GO:0071378),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,SOCS2
negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,HNRNPU
nucleotide-sugar metabolic process (GO:0009225),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,UGP2
P-body assembly (GO:0033962),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,DYNC1H1
dosage compensation by inactivation of X chromosome (GO:0009048),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,HNRNPU
double-strand break repair via break-induced replication (GO:0000727),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,MCM7
regulation of response to oxidative stress (GO:1902882),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,MACROH2A1
positive regulation of myeloid leukocyte mediated immunity (GO:0002888),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,CAMK4
positive regulation of protein maturation (GO:1903319),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,SOX4
mitotic G1/S transition checkpoint signaling (GO:0044819),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,PRKDC
morphogenesis of a polarized epithelium (GO:0001738),1/12,0.06574955100746059,0.20765082079371136,0,0,16.133116883116884,43.91277015622912,ACTG1
regulation of hematopoietic progenitor cell differentiation (GO:1901532),2/75,0.06727253246412589,0.2105071017949529,0,0,4.890534369986425,13.199568214533345,PRKDC;MYB
import into nucleus (GO:0051170),2/77,0.07042613421332851,0.2105071017949529,0,0,4.75963963963964,12.628232389184484,NUP214;HNRNPA1
"negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,HMGB1
regulation of actomyosin structure organization (GO:0110020),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,ACTG1
negative regulation of histone methylation (GO:0031061),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,MACROH2A1
carboxylic acid biosynthetic process (GO:0046394),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,UGP2
regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,HMGB1
cardiac right ventricle morphogenesis (GO:0003215),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,SOX4
negative regulation of stem cell differentiation (GO:2000737),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,HNRNPU
regulation of interleukin-5 production (GO:0032674),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,LEF1
regulation of nucleocytoplasmic transport (GO:0046822),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,NUP214
embryonic appendage morphogenesis (GO:0035113),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,MBNL1
regulation of response to stress (GO:0080134),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,MACROH2A1
positive regulation of cellular carbohydrate metabolic process (GO:0010676),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,PMAIP1
regulation of T cell differentiation in thymus (GO:0033081),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,CAMK4
glucan biosynthetic process (GO:0009250),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,UGP2
glycogen biosynthetic process (GO:0005978),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,UGP2
kinetochore organization (GO:0051383),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,CENPF
positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,BTG2
spinal cord development (GO:0021510),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,SOX4
mitochondrial outer membrane permeabilization (GO:0097345),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,PMAIP1
negative regulation by host of viral transcription (GO:0043922),1/13,0.07103122432967693,0.2105071017949529,0,0,14.787946428571429,39.108731340452245,JUN
neuron projection development (GO:0031175),3/171,0.07286723686954918,0.21534507432397496,0,0,3.2011363636363637,8.384148001642442,BTG2;STMN1;HMGB1
regulation of neuron differentiation (GO:0045664),2/79,0.07362730616661911,0.21695627154379446,0,0,4.635544635544636,12.092927534192786,NREP;FGFR1
rRNA processing (GO:0006364),3/173,0.07487542926013473,0.21695627154379446,0,0,3.1631550802139037,8.198674932392958,RPS27;RPL21;PRKDC
antigen processing and presentation of endogenous peptide antigen (GO:0002483),1/14,0.0762833015257954,0.21695627154379446,0,0,13.649725274725276,35.124854668215484,ERAP2
"negative regulation of DNA-templated transcription, elongation (GO:0032785)",1/14,0.0762833015257954,0.21695627154379446,0,0,13.649725274725276,35.124854668215484,HNRNPU
regulation of cell projection organization (GO:0031344),1/14,0.0762833015257954,0.21695627154379446,0,0,13.649725274725276,35.124854668215484,MACF1
"negative regulation of mRNA splicing, via spliceosome (GO:0048025)",1/14,0.0762833015257954,0.21695627154379446,0,0,13.649725274725276,35.124854668215484,SRSF10
positive regulation of brown fat cell differentiation (GO:0090336),1/14,0.0762833015257954,0.21695627154379446,0,0,13.649725274725276,35.124854668215484,HNRNPU
regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),1/14,0.0762833015257954,0.21695627154379446,0,0,13.649725274725276,35.124854668215484,MACROH2A1
positive regulation of glucose metabolic process (GO:0010907),1/14,0.0762833015257954,0.21695627154379446,0,0,13.649725274725276,35.124854668215484,PMAIP1
response to X-ray (GO:0010165),1/14,0.0762833015257954,0.21695627154379446,0,0,13.649725274725276,35.124854668215484,NUCKS1
positive regulation of leukocyte degranulation (GO:0043302),1/14,0.0762833015257954,0.21695627154379446,0,0,13.649725274725276,35.124854668215484,GAB2
secondary palate development (GO:0062009),1/14,0.0762833015257954,0.21695627154379446,0,0,13.649725274725276,35.124854668215484,LEF1
T cell differentiation in thymus (GO:0033077),1/14,0.0762833015257954,0.21695627154379446,0,0,13.649725274725276,35.124854668215484,RAG1
positive regulation of T-helper cell differentiation (GO:0045624),1/14,0.0762833015257954,0.21695627154379446,0,0,13.649725274725276,35.124854668215484,MYB
negative regulation of protein modification process (GO:0031400),2/81,0.07687459809895823,0.21746878285748078,0,0,4.517732922796214,11.590604242007029,PRKDC;PPIA
positive regulation of cellular amide metabolic process (GO:0034250),2/81,0.07687459809895823,0.21746878285748078,0,0,4.517732922796214,11.590604242007029,PRKDC;SOX4
defense response to bacterium (GO:0042742),3/176,0.07793358866173053,0.21973344955647217,0,0,3.1078297425118233,7.930865257521176,H2BC21;H2BC11;HMGB2
"regulation of gene expression, epigenetic (GO:0040029)",2/82,0.07851509301501222,0.21973344955647217,0,0,4.461036036036036,11.350947402971807,DEK;MACROH2A1
regulation of mitotic cell cycle (GO:0007346),3/178,0.08000257161640492,0.21973344955647217,0,0,3.072,7.7589396468321485,BTG2;HNRNPU;MKI67
negative regulation of mRNA processing (GO:0050686),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,SRSF10
cellular response to arsenic-containing substance (GO:0071243),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,HNRNPA1
regulation of extracellular matrix disassembly (GO:0010715),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,DPP4
regulation of lymphocyte activation (GO:0051249),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,PAG1
regulation of neuron projection arborization (GO:0150011),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,MACF1
regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,BTG2
regulation of phospholipase C activity (GO:1900274),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,FGFR1
establishment of spindle localization (GO:0051293),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,DYNC1H1
"positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,PMAIP1
positive regulation of endothelial cell chemotaxis (GO:2001028),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,FGFR1
positive regulation of histone H3-K4 methylation (GO:0051571),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,MYB
positive regulation of keratinocyte differentiation (GO:0045618),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,MACROH2A1
modulation by host of viral genome replication (GO:0044827),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,NUCKS1
myoblast differentiation (GO:0045445),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,MBNL1
protein localization to cell-cell junction (GO:0150105),1/15,0.08150594689102497,0.21973344955647217,0,0,12.674107142857142,31.77499158030827,ACTG1
regulation of cell migration (GO:0030334),5/408,0.08173784406644834,0.21973344955647217,0,0,2.238305302821432,5.605249590426683,MACF1;LEF1;TMSB10;SYNE2;ACTG1
lymphocyte differentiation (GO:0030098),2/84,0.08182890276488661,0.21973344955647217,0,0,4.351790815205449,10.893075354012982,SOX4;RAG1
glucose homeostasis (GO:0042593),2/86,0.08518532035645178,0.22318220109450734,0,0,4.247747747747748,10.46188903319615,NUCKS1;SOX4
positive regulation of endothelial cell migration (GO:0010595),2/86,0.08518532035645178,0.22318220109450734,0,0,4.247747747747748,10.46188903319615,HMGB1;FGFR1
negative regulation of histone modification (GO:0031057),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,MACROH2A1
cellular response to corticosteroid stimulus (GO:0071384),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,HNRNPU
regulation of interleukin-1 production (GO:0032652),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,HMGB1
neural tube development (GO:0021915),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,SOX4
regulation of interleukin-13 production (GO:0032656),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,LEF1
regulation of mast cell degranulation (GO:0043304),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,GAB2
DNA unwinding involved in DNA replication (GO:0006268),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,MCM7
regulation of phosphate metabolic process (GO:0019220),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,MCM7
positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,PRKDC
resolution of meiotic recombination intermediates (GO:0000712),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,TOP2A
retrograde axonal transport (GO:0008090),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,DYNC1H1
positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,CAMK4
sympathetic nervous system development (GO:0048485),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,SOX4
positive regulation of small molecule metabolic process (GO:0062013),1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,PMAIP1
"mRNA cis splicing, via spliceosome (GO:0045292)",1/16,0.08669932386563564,0.22318220109450734,0,0,11.82857142857143,28.924514463533246,SNRNP200
regulation of cell cycle (GO:0051726),4/296,0.08709514524515316,0.22365695065381563,0,0,2.4626115370114365,6.010629290358642,JUN;CENPF;SON;HNRNPU
negative regulation of binding (GO:0051100),2/88,0.08858298527055891,0.22692687267857464,0,0,4.148543892729939,10.055304905201277,JUN;LEF1
regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),2/89,0.09029686708945786,0.2301601757140656,0,0,4.100652376514446,9.86064404470817,PMAIP1;HMGB1
transforming growth factor beta receptor signaling pathway (GO:0007179),2/89,0.09029686708945786,0.2301601757140656,0,0,4.100652376514446,9.86064404470817,JUN;UBC
negative regulation of phagocytosis (GO:0050765),1/17,0.0918635949518264,0.2301601757140656,0,0,11.088727678571429,26.47378806059708,HMGB1
DNA biosynthetic process (GO:0071897),1/17,0.0918635949518264,0.2301601757140656,0,0,11.088727678571429,26.47378806059708,PPIA
embryo development ending in birth or egg hatching (GO:0009792),1/17,0.0918635949518264,0.2301601757140656,0,0,11.088727678571429,26.47378806059708,FGFR1
positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),1/17,0.0918635949518264,0.2301601757140656,0,0,11.088727678571429,26.47378806059708,CCND3
maturation of 5.8S rRNA (GO:0000460),1/17,0.0918635949518264,0.2301601757140656,0,0,11.088727678571429,26.47378806059708,PRKDC
positive regulation of stem cell proliferation (GO:2000648),1/17,0.0918635949518264,0.2301601757140656,0,0,11.088727678571429,26.47378806059708,HNRNPU
negative regulation of protein kinase activity (GO:0006469),2/90,0.09202056174579372,0.2301601757140656,0,0,4.0538493038493035,9.671443530752793,PPIA;MACROH2A1
SRP-dependent cotranslational protein targeting to membrane (GO:0006614),2/90,0.09202056174579372,0.2301601757140656,0,0,4.0538493038493035,9.671443530752793,RPS27;RPL21
MAPK cascade (GO:0000165),4/303,0.09293887098915456,0.23113707041589007,0,0,2.404099291215366,5.711691078133873,UBC;SPTBN1;DUSP6;FGFR1
toll-like receptor signaling pathway (GO:0002224),2/91,0.09375390607239202,0.23113707041589007,0,0,4.008097985626075,9.487496396518234,UBC;HMGB1
T cell activation (GO:0042110),2/92,0.09549673840912326,0.23113707041589007,0,0,3.963363363363363,9.308605619765226,DPP4;SOX4
Wnt signaling pathway (GO:0016055),2/92,0.09549673840912326,0.23113707041589007,0,0,3.963363363363363,9.308605619765226,LEF1;UBC
regulation of nucleic acid-templated transcription (GO:1903506),5/430,0.09683808906209244,0.23113707041589007,0,0,2.1200435729847493,4.9496972761954074,NONO;MYB;NSD2;SRSF10;SOX4
regulation of brown fat cell differentiation (GO:0090335),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,HNRNPU
negative regulation of leukocyte cell-cell adhesion (GO:1903038),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,PAG1
regulation of chromosome segregation (GO:0051983),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,MKI67
cellular response to glucocorticoid stimulus (GO:0071385),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,HNRNPU
negative regulation of Rho protein signal transduction (GO:0035024),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,STMN1
negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,H2BC11
DNA strand elongation (GO:0022616),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,MCM7
DNA strand elongation involved in DNA replication (GO:0006271),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,MCM7
regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,PPIA
regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,TOP2A
regulation of spindle organization (GO:0090224),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,DYNC1H1
positive regulation of glial cell differentiation (GO:0045687),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,CXCR4
response to axon injury (GO:0048678),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,NREP
"positive regulation of mRNA splicing, via spliceosome (GO:0048026)",1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,TRA2B
positive regulation of response to endoplasmic reticulum stress (GO:1905898),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,PMAIP1
microtubule depolymerization (GO:0007019),1/18,0.09699892180024121,0.23113707041589007,0,0,10.4359243697479,24.3475898718272,STMN1
cytoplasmic translation (GO:0002181),2/93,0.09724889858789067,0.23121198810334453,0,0,3.9196119196119197,9.134583544506325,RPS27;RPL21
negative regulation of MAPK cascade (GO:0043409),2/94,0.099010227911688,0.23181884580347892,0,0,3.8768115942028984,8.965251342321519,PPIA;DUSP6
regulation of kinase activity (GO:0043549),2/94,0.099010227911688,0.23181884580347892,0,0,3.8768115942028984,8.965251342321519,HNRNPU;FGFR1
cotranslational protein targeting to membrane (GO:0006613),2/94,0.099010227911688,0.23181884580347892,0,0,3.8768115942028984,8.965251342321519,RPS27;RPL21
ciliary basal body-plasma membrane docking (GO:0097711),2/95,0.10078056914414095,0.23181884580347892,0,0,3.834931705899448,8.800438509572151,DYNC1H1;TUBB
regulation of signal transduction (GO:0009966),3/198,0.10196100060169108,0.23181884580347892,0,0,2.754125874125874,6.288123487024435,SOCS2;NUCKS1;PPIA
atrioventricular valve morphogenesis (GO:0003181),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,SOX4
negative regulation of RNA splicing (GO:0033119),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,SRSF10
cellular response to interleukin-7 (GO:0098761),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,SOCS2
cytoplasmic translational initiation (GO:0002183),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,EIF3A
regulation of mitochondrial membrane permeability (GO:0046902),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,PMAIP1
nucleotide-sugar biosynthetic process (GO:0009226),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,UGP2
regulation of mitotic spindle assembly (GO:1901673),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,HNRNPU
regulation of oligodendrocyte differentiation (GO:0048713),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,CXCR4
endoplasmic reticulum mannose trimming (GO:1904380),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,UBC
establishment of skin barrier (GO:0061436),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,STMN1
regulation of water loss via skin (GO:0033561),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,STMN1
interleukin-7-mediated signaling pathway (GO:0038111),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,SOCS2
positive regulation of monocyte chemotaxis (GO:0090026),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,HMGB1
long-term memory (GO:0007616),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,CAMK4
maintenance of protein localization in organelle (GO:0072595),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,HNRNPU
telomere capping (GO:0016233),1/19,0.10210546516485934,0.23181884580347892,0,0,9.855654761904763,22.48813067007111,PRKDC
double-strand break repair via homologous recombination (GO:0000724),2/97,0.10434766572490813,0.23526975361653885,0,0,3.7538169748696064,8.483727773995065,MCM7;NUCKS1
positive regulation of cold-induced thermogenesis (GO:0120162),2/97,0.10434766572490813,0.23526975361653885,0,0,3.7538169748696064,8.483727773995065,DYNC1H1;CXCR4
negative regulation of viral life cycle (GO:1903901),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,PPIA
regulation of lymphocyte differentiation (GO:0045619),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,PRKDC
regulation of nuclear division (GO:0051783),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,MKI67
regulation of protein localization to cell periphery (GO:1904375),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,SPTBN1
energy reserve metabolic process (GO:0006112),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,UGP2
positive regulation of activated T cell proliferation (GO:0042104),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,HMGB1
positive regulation of cyclin-dependent protein kinase activity (GO:1904031),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,CCND3
positive regulation of epidermal cell differentiation (GO:0045606),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,MACROH2A1
growth hormone receptor signaling pathway (GO:0060396),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,SOCS2
positive regulation of lymphocyte differentiation (GO:0045621),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,PRKDC
positive regulation of peptidyl-lysine acetylation (GO:2000758),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,SOX4
maintenance of protein location in nucleus (GO:0051457),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,HNRNPU
post-transcriptional gene silencing by RNA (GO:0035194),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,CNOT6
natural killer cell mediated immunity (GO:0002228),1/20,0.10718338491793168,0.23526975361653885,0,0,9.336466165413533,20.850327266654197,TUBB
axon guidance (GO:0007411),3/203,0.1077917104737656,0.23597107239825071,0,0,2.6845909090909092,5.980072615879979,CXCR4;GAB2;SPTBN1
mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),2/99,0.1079489593957971,0.23597107239825071,0,0,3.6760471812018203,8.183236726130872,NUP214;SRSF3
regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),2/100,0.10976205232938706,0.238918198779294,0,0,3.6383526383526386,8.038723369904124,UBC;NREP
positive regulation of translation (GO:0045727),2/100,0.10976205232938706,0.238918198779294,0,0,3.6383526383526386,8.038723369904124,PRKDC;SOX4
cellular response to oxygen-containing compound (GO:1901701),4/323,0.11062831270537524,0.238918198779294,0,0,2.251071295044721,4.95591181009237,H2AZ1;JUN;HMGB2;HMGB1
cellular response to chemical stress (GO:0062197),2/101,0.11158324398886037,0.238918198779294,0,0,3.6014196014196016,7.897856945340056,PPIA;ETV5
actin filament-based transport (GO:0099515),1/21,0.11223284006929028,0.238918198779294,0,0,8.869196428571428,19.398525820511633,SYNE2
autonomic nervous system development (GO:0048483),1/21,0.11223284006929028,0.238918198779294,0,0,8.869196428571428,19.398525820511633,SOX4
cellular response to estradiol stimulus (GO:0071392),1/21,0.11223284006929028,0.238918198779294,0,0,8.869196428571428,19.398525820511633,H2AZ1
nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),1/21,0.11223284006929028,0.238918198779294,0,0,8.869196428571428,19.398525820511633,CNOT6
error-prone translesion synthesis (GO:0042276),1/21,0.11223284006929028,0.238918198779294,0,0,8.869196428571428,19.398525820511633,UBC
spindle assembly checkpoint signaling (GO:0071173),1/21,0.11223284006929028,0.238918198779294,0,0,8.869196428571428,19.398525820511633,CENPF
positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),1/21,0.11223284006929028,0.238918198779294,0,0,8.869196428571428,19.398525820511633,JUN
mitotic spindle assembly checkpoint signaling (GO:0007094),1/21,0.11223284006929028,0.238918198779294,0,0,8.869196428571428,19.398525820511633,CENPF
mitotic spindle checkpoint signaling (GO:0071174),1/21,0.11223284006929028,0.238918198779294,0,0,8.869196428571428,19.398525820511633,CENPF
positive regulation of cell growth (GO:0030307),2/102,0.11341238709229966,0.2390264355527027,0,0,3.5652252252252254,7.760513666329722,H1-5;MACF1
positive regulation of cellular protein metabolic process (GO:0032270),2/102,0.11341238709229966,0.2390264355527027,0,0,3.5652252252252254,7.760513666329722,PRKDC;SOX4
intrinsic apoptotic signaling pathway (GO:0097193),2/102,0.11341238709229966,0.2390264355527027,0,0,3.5652252252252254,7.760513666329722,PRKDC;PMAIP1
regulation of transcription by RNA polymerase II (GO:0006357),17/2206,0.11473522084265592,0.2390264355527027,0,0,1.4317134917009289,3.099843302070299,H2AZ1;JUN;CBX5;PRKDC;LEF1;HMGB2;HNRNPU;NUCKS1;HMGB1;DEK;MACROH2A1;ETV5;H1-5;TFDP2;MYB;UBC;SOX4
mitotic cell cycle phase transition (GO:0044772),3/209,0.11495660126325544,0.2390264355527027,0,0,2.6056045895851723,5.63644541719265,DYNC1H1;CCND3;TUBB
protein targeting to ER (GO:0045047),2/103,0.1152493357499096,0.2390264355527027,0,0,3.52974756935153,7.626575067062628,RPS27;RPL21
regulation of insulin secretion (GO:0050796),2/104,0.11709394540604319,0.2390264355527027,0,0,3.494965553789083,7.495927726592786,DPP4;SOX4
mRNA transport (GO:0051028),2/104,0.11709394540604319,0.2390264355527027,0,0,3.494965553789083,7.495927726592786,NUP214;SRSF3
negative regulation of lymphocyte activation (GO:0051250),1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,PAG1
negative regulation of mitotic metaphase/anaphase transition (GO:0045841),1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,CENPF
regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,PMAIP1
"nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,UBC
osteoclast differentiation (GO:0030316),1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,GAB2
peptidyl-threonine dephosphorylation (GO:0035970),1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,DUSP6
error-free translesion synthesis (GO:0070987),1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,UBC
positive regulation of axon extension (GO:0045773),1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,MACF1
"positive regulation of DNA-templated transcription, initiation (GO:2000144)",1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,JUN
regulation of voltage-gated calcium channel activity (GO:1901385),1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,AHNAK
limb morphogenesis (GO:0035108),1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,MBNL1
lipid droplet organization (GO:0034389),1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,PPIA
positive regulation of signal transduction by p53 class mediator (GO:1901798),1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,PMAIP1
natural killer cell mediated cytotoxicity (GO:0042267),1/22,0.1172539887068551,0.2390264355527027,0,0,8.446428571428571,18.104183565431285,TUBB
regulation of cell cycle process (GO:0010564),2/106,0.12080557649998248,0.24485114930456217,0,0,3.4274081774081773,7.244076806119736,DYNC1H1;MKI67
positive regulation of protein serine/threonine kinase activity (GO:0071902),2/106,0.12080557649998248,0.24485114930456217,0,0,3.4274081774081773,7.244076806119736,CCND3;FGFR1
protein localization to nucleus (GO:0034504),2/106,0.12080557649998248,0.24485114930456217,0,0,3.4274081774081773,7.244076806119736,NUP214;HNRNPU
negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),1/23,0.12224698812022401,0.2454218471180209,0,0,8.062094155844155,16.944198323174863,STMN1
regulation of interleukin-4 production (GO:0032673),1/23,0.12224698812022401,0.2454218471180209,0,0,8.062094155844155,16.944198323174863,LEF1
"nucleotide-excision repair, DNA damage recognition (GO:0000715)",1/23,0.12224698812022401,0.2454218471180209,0,0,8.062094155844155,16.944198323174863,UBC
positive regulation of mRNA processing (GO:0050685),1/23,0.12224698812022401,0.2454218471180209,0,0,8.062094155844155,16.944198323174863,TRA2B
vesicle transport along microtubule (GO:0047496),1/23,0.12224698812022401,0.2454218471180209,0,0,8.062094155844155,16.944198323174863,DYNC1H1
mRNA export from nucleus (GO:0006406),2/107,0.12267231558356485,0.2458092990291887,0,0,3.3945945945945946,7.122669340441486,NUP214;SRSF3
regulation of protein ubiquitination (GO:0031396),2/109,0.12642694508704921,0.24984719499659985,0,0,3.3308074429569756,6.888411719172781,HUWE1;SOX4
regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),1/24,0.12721199471109496,0.24984719499659985,0,0,7.711180124223603,15.899684877362125,NREP
negative regulation of stress fiber assembly (GO:0051497),1/24,0.12721199471109496,0.24984719499659985,0,0,7.711180124223603,15.899684877362125,STMN1
"nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",1/24,0.12721199471109496,0.24984719499659985,0,0,7.711180124223603,15.899684877362125,UBC
"nucleotide-excision repair, DNA gap filling (GO:0006297)",1/24,0.12721199471109496,0.24984719499659985,0,0,7.711180124223603,15.899684877362125,UBC
dendritic cell differentiation (GO:0097028),1/24,0.12721199471109496,0.24984719499659985,0,0,7.711180124223603,15.899684877362125,CAMK4
histone monoubiquitination (GO:0010390),1/24,0.12721199471109496,0.24984719499659985,0,0,7.711180124223603,15.899684877362125,RAG1
positive regulation of phospholipase activity (GO:0010518),1/24,0.12721199471109496,0.24984719499659985,0,0,7.711180124223603,15.899684877362125,FGFR1
"protein alpha-1,2-demannosylation (GO:0036508)",1/24,0.12721199471109496,0.24984719499659985,0,0,7.711180124223603,15.899684877362125,UBC
protein insertion into mitochondrial membrane (GO:0051204),1/24,0.12721199471109496,0.24984719499659985,0,0,7.711180124223603,15.899684877362125,PMAIP1
cellular response to lipid (GO:0071396),3/219,0.12728510217690672,0.24984719499659985,0,0,2.4837121212121214,5.119739898856916,H2AZ1;HMGB2;HMGB1
"regulation of transcription, DNA-templated (GO:0006355)",17/2244,0.12834241712365604,0.2514560691052372,0,0,1.404262086513995,2.8830251257549016,JUN;CBX5;NONO;LEF1;HMGB2;NUCKS1;HMGB1;DEK;ETV5;CENPF;TFDP2;CAMK4;MYB;NSD2;CD38;SRSF10;SOX4
positive regulation of cell motility (GO:2000147),3/221,0.12980621285283914,0.25328589761592196,0,0,2.460675562969141,5.023992328601324,LEF1;SYNE2;ACTG1
regulation of protein serine/threonine kinase activity (GO:0071900),2/111,0.13020886387236086,0.25328589761592196,0,0,3.2693611042234894,6.66497013267866,CCND3;MACROH2A1
Fc-epsilon receptor signaling pathway (GO:0038095),2/111,0.13020886387236086,0.25328589761592196,0,0,3.2693611042234894,6.66497013267866,JUN;GAB2
positive regulation of multicellular organismal process (GO:0051240),4/345,0.1316862595339811,0.25328589761592196,0,0,2.1034733245446473,4.264440900682504,DYNC1H1;LEF1;CXCR4;MACROH2A1
Fc receptor signaling pathway (GO:0038093),2/112,0.1321097194402483,0.25328589761592196,0,0,3.2394758394758396,6.557095914730366,JUN;GAB2
receptor signaling pathway via STAT (GO:0097696),1/25,0.1321491639735245,0.25328589761592196,0,0,7.389508928571429,14.955065254027492,SOCS2
peptide catabolic process (GO:0043171),1/25,0.1321491639735245,0.25328589761592196,0,0,7.389508928571429,14.955065254027492,ERAP2
regulation of neutrophil chemotaxis (GO:0090022),1/25,0.1321491639735245,0.25328589761592196,0,0,7.389508928571429,14.955065254027492,DPP4
response to dsRNA (GO:0043331),1/25,0.1321491639735245,0.25328589761592196,0,0,7.389508928571429,14.955065254027492,PMAIP1
in utero embryonic development (GO:0001701),1/25,0.1321491639735245,0.25328589761592196,0,0,7.389508928571429,14.955065254027492,MBNL1
positive regulation of release of cytochrome c from mitochondria (GO:0090200),1/25,0.1321491639735245,0.25328589761592196,0,0,7.389508928571429,14.955065254027492,PMAIP1
negative regulation of actin filament polymerization (GO:0030837),1/25,0.1321491639735245,0.25328589761592196,0,0,7.389508928571429,14.955065254027492,TMSB10
"nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",2/113,0.13401699512103082,0.2559385935704885,0,0,3.210129047966886,6.451680950716528,RPS27;RPL21
positive regulation of metabolic process (GO:0009893),2/113,0.13401699512103082,0.2559385935704885,0,0,3.210129047966886,6.451680950716528,DYNC1H1;CXCR4
cellular response to transforming growth factor beta stimulus (GO:0071560),2/114,0.1359305594915406,0.25710647580212,0,0,3.1813063063063063,6.348650227045803,JUN;UBC
response to lipid (GO:0033993),2/114,0.1359305594915406,0.25710647580212,0,0,3.1813063063063063,6.348650227045803,SOCS2;HMGB2
neutrophil degranulation (GO:0043312),5/481,0.13681229480238558,0.25710647580212,0,0,1.8879357298474946,3.7553786792158297,DYNC1H1;TUBB;HUWE1;HMGB1;PPIA
regulation of actin filament bundle assembly (GO:0032231),1/26,0.13705865061663106,0.25710647580212,0,0,7.093571428571429,14.097383202443446,ACTG1
regulation of monocyte chemotaxis (GO:0090025),1/26,0.13705865061663106,0.25710647580212,0,0,7.093571428571429,14.097383202443446,HMGB1
glial cell development (GO:0021782),1/26,0.13705865061663106,0.25710647580212,0,0,7.093571428571429,14.097383202443446,SOX4
global genome nucleotide-excision repair (GO:0070911),1/26,0.13705865061663106,0.25710647580212,0,0,7.093571428571429,14.097383202443446,UBC
regulation of viral life cycle (GO:1903900),1/26,0.13705865061663106,0.25710647580212,0,0,7.093571428571429,14.097383202443446,PPIA
positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),1/26,0.13705865061663106,0.25710647580212,0,0,7.093571428571429,14.097383202443446,CCND3
positive regulation of interleukin-2 production (GO:0032743),1/26,0.13705865061663106,0.25710647580212,0,0,7.093571428571429,14.097383202443446,SPTBN1
supramolecular fiber organization (GO:0097435),4/351,0.13770075551079808,0.2576777363775739,0,0,2.066467493324168,4.097128036859953,DYNC1H1;TPM4;STMN1;UBC
cellular response to molecule of bacterial origin (GO:0071219),2/115,0.13785028240993086,0.2576777363775739,0,0,3.152993701666268,6.247931623024015,HMGB2;HMGB1
neutrophil activation involved in immune response (GO:0002283),5/485,0.1402221438547789,0.25981516218327466,0,0,1.8718171296296295,3.6772359867187463,DYNC1H1;TUBB;HUWE1;HMGB1;PPIA
protein peptidyl-prolyl isomerization (GO:0000413),1/27,0.1419406084517323,0.25981516218327466,0,0,6.820398351648351,13.315781254294897,PPIA
negative regulation of protein polymerization (GO:0032272),1/27,0.1419406084517323,0.25981516218327466,0,0,6.820398351648351,13.315781254294897,STMN1
cellular response to cadmium ion (GO:0071276),1/27,0.1419406084517323,0.25981516218327466,0,0,6.820398351648351,13.315781254294897,JUN
cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),1/27,0.1419406084517323,0.25981516218327466,0,0,6.820398351648351,13.315781254294897,UBC
regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),1/27,0.1419406084517323,0.25981516218327466,0,0,6.820398351648351,13.315781254294897,HNRNPU
response to glucocorticoid (GO:0051384),1/27,0.1419406084517323,0.25981516218327466,0,0,6.820398351648351,13.315781254294897,HNRNPU
stress-activated protein kinase signaling cascade (GO:0031098),1/27,0.1419406084517323,0.25981516218327466,0,0,6.820398351648351,13.315781254294897,UBC
microtubule polymerization or depolymerization (GO:0031109),1/27,0.1419406084517323,0.25981516218327466,0,0,6.820398351648351,13.315781254294897,STMN1
positive regulation of toll-like receptor signaling pathway (GO:0034123),1/27,0.1419406084517323,0.25981516218327466,0,0,6.820398351648351,13.315781254294897,HMGB1
protein export from nucleus (GO:0006611),1/27,0.1419406084517323,0.25981516218327466,0,0,6.820398351648351,13.315781254294897,NUP214
negative regulation of actin filament bundle assembly (GO:0032232),1/27,0.1419406084517323,0.25981516218327466,0,0,6.820398351648351,13.315781254294897,STMN1
apoptotic process (GO:0006915),3/231,0.1426725534186963,0.260494465349754,0,0,2.351555023923445,4.578955257422812,PMAIP1;CXCR4;PPIA
neutrophil mediated immunity (GO:0002446),5/488,0.14280414924655702,0.260494465349754,0,0,1.8599033816425121,3.619894935569477,DYNC1H1;TUBB;HUWE1;HMGB1;PPIA
positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),2/119,0.1455881995811384,0.2627907132368307,0,0,3.0445830445830446,5.866829911799462,PMAIP1;HMGB1
negative regulation of oxidative stress-induced cell death (GO:1903202),1/28,0.14679519047539408,0.2627907132368307,0,0,6.567460317460317,12.60109727041828,PPIA
"regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",1/28,0.14679519047539408,0.2627907132368307,0,0,6.567460317460317,12.60109727041828,PMAIP1
regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),1/28,0.14679519047539408,0.2627907132368307,0,0,6.567460317460317,12.60109727041828,FGFR1
regulation of microtubule polymerization or depolymerization (GO:0031110),1/28,0.14679519047539408,0.2627907132368307,0,0,6.567460317460317,12.60109727041828,STMN1
nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),1/28,0.14679519047539408,0.2627907132368307,0,0,6.567460317460317,12.60109727041828,UBC
regulation of multicellular organismal development (GO:2000026),1/28,0.14679519047539408,0.2627907132368307,0,0,6.567460317460317,12.60109727041828,DUSP6
glycogen metabolic process (GO:0005977),1/28,0.14679519047539408,0.2627907132368307,0,0,6.567460317460317,12.60109727041828,UGP2
positive regulation of response to wounding (GO:1903036),1/28,0.14679519047539408,0.2627907132368307,0,0,6.567460317460317,12.60109727041828,ACTG1
ventricular septum morphogenesis (GO:0060412),1/28,0.14679519047539408,0.2627907132368307,0,0,6.567460317460317,12.60109727041828,SOX4
protein depolymerization (GO:0051261),1/28,0.14679519047539408,0.2627907132368307,0,0,6.567460317460317,12.60109727041828,STMN1
cellular response to lipopolysaccharide (GO:0071222),2/120,0.14753680602397198,0.2636721972523013,0,0,3.0186287982898152,5.776682319931852,HMGB2;HMGB1
regulation of mRNA catabolic process (GO:0061013),2/122,0.151450107430436,0.2651514985912783,0,0,2.968018018018018,5.602131136452085,NUP214;UBC
regulation of calcium ion transmembrane transporter activity (GO:1901019),1/29,0.1516225488163737,0.2651514985912783,0,0,6.332589285714286,11.945549951152008,AHNAK
beta-catenin-TCF complex assembly (GO:1904837),1/29,0.1516225488163737,0.2651514985912783,0,0,6.332589285714286,11.945549951152008,LEF1
negative regulation of interferon-gamma production (GO:0032689),1/29,0.1516225488163737,0.2651514985912783,0,0,6.332589285714286,11.945549951152008,HMGB1
negative regulation of mRNA catabolic process (GO:1902373),1/29,0.1516225488163737,0.2651514985912783,0,0,6.332589285714286,11.945549951152008,HNRNPU
regulation of double-strand break repair via nonhomologous end joining (GO:2001032),1/29,0.1516225488163737,0.2651514985912783,0,0,6.332589285714286,11.945549951152008,PRKDC
negative regulation of transferase activity (GO:0051348),1/29,0.1516225488163737,0.2651514985912783,0,0,6.332589285714286,11.945549951152008,HNRNPU
"nucleotide-excision repair, preincision complex assembly (GO:0006294)",1/29,0.1516225488163737,0.2651514985912783,0,0,6.332589285714286,11.945549951152008,UBC
glial cell differentiation (GO:0010001),1/29,0.1516225488163737,0.2651514985912783,0,0,6.332589285714286,11.945549951152008,SOX4
positive regulation of dephosphorylation (GO:0035306),1/29,0.1516225488163737,0.2651514985912783,0,0,6.332589285714286,11.945549951152008,PPIA
positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),1/29,0.1516225488163737,0.2651514985912783,0,0,6.332589285714286,11.945549951152008,PMAIP1
response to cadmium ion (GO:0046686),1/29,0.1516225488163737,0.2651514985912783,0,0,6.332589285714286,11.945549951152008,JUN
MyD88-dependent toll-like receptor signaling pathway (GO:0002755),1/29,0.1516225488163737,0.2651514985912783,0,0,6.332589285714286,11.945549951152008,UBC
axonogenesis (GO:0007409),3/240,0.15460168225753798,0.26909814502035606,0,0,2.2612197928653623,4.221478606342553,CXCR4;GAB2;SPTBN1
protein transport (GO:0015031),4/369,0.15639040476500352,0.26909814502035606,0,0,1.9627497800678648,3.641685555983479,ARL4C;MACF1;CENPF;SPTBN1
"negative regulation of gene expression, epigenetic (GO:0045814)",1/30,0.1564228347708119,0.26909814502035606,0,0,6.113916256157635,11.34249133434297,MACROH2A1
regulation of protein localization to membrane (GO:1905475),1/30,0.1564228347708119,0.26909814502035606,0,0,6.113916256157635,11.34249133434297,SPTBN1
positive regulation of B cell proliferation (GO:0030890),1/30,0.1564228347708119,0.26909814502035606,0,0,6.113916256157635,11.34249133434297,CD38
RNA-dependent DNA biosynthetic process (GO:0006278),1/30,0.1564228347708119,0.26909814502035606,0,0,6.113916256157635,11.34249133434297,PPIA
maintenance of blood-brain barrier (GO:0035633),1/30,0.1564228347708119,0.26909814502035606,0,0,6.113916256157635,11.34249133434297,ACTG1
TRIF-dependent toll-like receptor signaling pathway (GO:0035666),1/30,0.1564228347708119,0.26909814502035606,0,0,6.113916256157635,11.34249133434297,UBC
morphogenesis of an epithelium (GO:0002009),1/30,0.1564228347708119,0.26909814502035606,0,0,6.113916256157635,11.34249133434297,ACTG1
mRNA splice site selection (GO:0006376),1/30,0.1564228347708119,0.26909814502035606,0,0,6.113916256157635,11.34249133434297,SRSF10
regulation of phosphorylation (GO:0042325),2/125,0.15735847387274893,0.26983025179476233,0,0,2.895187870797627,5.3538648015451065,NUP214;MCM7
regulation of protein secretion (GO:0050708),2/125,0.15735847387274893,0.26983025179476233,0,0,2.895187870797627,5.3538648015451065,DPP4;PPIA
activation of protein kinase B activity (GO:0032148),1/31,0.1611961988204034,0.27331022171792757,0,0,5.909821428571429,10.786210288951333,PPIA
receptor signaling pathway via JAK-STAT (GO:0007259),1/31,0.1611961988204034,0.27331022171792757,0,0,5.909821428571429,10.786210288951333,SOCS2
regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),1/31,0.1611961988204034,0.27331022171792757,0,0,5.909821428571429,10.786210288951333,NREP
positive regulation of mononuclear cell migration (GO:0071677),1/31,0.1611961988204034,0.27331022171792757,0,0,5.909821428571429,10.786210288951333,HMGB1
positive regulation of protein targeting to mitochondrion (GO:1903955),1/31,0.1611961988204034,0.27331022171792757,0,0,5.909821428571429,10.786210288951333,HUWE1
positive regulation of RNA splicing (GO:0033120),1/31,0.1611961988204034,0.27331022171792757,0,0,5.909821428571429,10.786210288951333,TRA2B
MyD88-independent toll-like receptor signaling pathway (GO:0002756),1/31,0.1611961988204034,0.27331022171792757,0,0,5.909821428571429,10.786210288951333,UBC
DNA-dependent DNA replication (GO:0006261),2/129,0.16530306486028484,0.2764842086003227,0,0,2.803433354614457,5.046109204312887,MCM7;UBC
positive regulation of macromolecule biosynthetic process (GO:0010557),2/129,0.16530306486028484,0.2764842086003227,0,0,2.803433354614457,5.046109204312887,PRKDC;SOX4
regulation of cell morphogenesis (GO:0022604),1/32,0.1659427906060538,0.2764842086003227,0,0,5.71889400921659,10.27177521427218,MACF1
negative regulation of microtubule polymerization or depolymerization (GO:0031111),1/32,0.1659427906060538,0.2764842086003227,0,0,5.71889400921659,10.27177521427218,STMN1
regulation of chemotaxis (GO:0050920),1/32,0.1659427906060538,0.2764842086003227,0,0,5.71889400921659,10.27177521427218,CXCR4
peptidyl-proline modification (GO:0018208),1/32,0.1659427906060538,0.2764842086003227,0,0,5.71889400921659,10.27177521427218,PPIA
regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),1/32,0.1659427906060538,0.2764842086003227,0,0,5.71889400921659,10.27177521427218,TFDP2
gene silencing by miRNA (GO:0035195),1/32,0.1659427906060538,0.2764842086003227,0,0,5.71889400921659,10.27177521427218,CNOT6
positive regulation of immune effector process (GO:0002699),1/32,0.1659427906060538,0.2764842086003227,0,0,5.71889400921659,10.27177521427218,MYB
positive regulation of interleukin-10 production (GO:0032733),1/32,0.1659427906060538,0.2764842086003227,0,0,5.71889400921659,10.27177521427218,HMGB1
mitochondrial membrane organization (GO:0007006),1/32,0.1659427906060538,0.2764842086003227,0,0,5.71889400921659,10.27177521427218,PMAIP1
G2/M transition of mitotic cell cycle (GO:0000086),2/130,0.1673003709231785,0.27830784974327494,0,0,2.781390765765766,4.973027821533084,DYNC1H1;TUBB
cell cycle G2/M phase transition (GO:0044839),2/131,0.16930191592116406,0.2803745325683573,0,0,2.75968992248062,4.9014070980900515,DYNC1H1;TUBB
cellular response to hypoxia (GO:0071456),2/131,0.16930191592116406,0.2803745325683573,0,0,2.75968992248062,4.9014070980900515,UBC;PMAIP1
antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),1/33,0.1706627589546523,0.2803745325683573,0,0,5.539899553571429,9.794907155612117,ERAP2
apoptotic cell clearance (GO:0043277),1/33,0.1706627589546523,0.2803745325683573,0,0,5.539899553571429,9.794907155612117,HMGB1
exonucleolytic catabolism of deadenylated mRNA (GO:0043928),1/33,0.1706627589546523,0.2803745325683573,0,0,5.539899553571429,9.794907155612117,CNOT6
RNA stabilization (GO:0043489),1/33,0.1706627589546523,0.2803745325683573,0,0,5.539899553571429,9.794907155612117,HNRNPU
signal transduction by p53 class mediator (GO:0072331),1/33,0.1706627589546523,0.2803745325683573,0,0,5.539899553571429,9.794907155612117,PMAIP1
positive regulation of telomere maintenance via telomerase (GO:0032212),1/33,0.1706627589546523,0.2803745325683573,0,0,5.539899553571429,9.794907155612117,HNRNPA1
positive regulation of phosphorylation (GO:0042327),3/253,0.17236058757430228,0.2806761187038066,0,0,2.142218181818182,3.7663763655965248,CCND3;PPIA;FGFR1
regulation of cell motility (GO:2000145),2/133,0.1733172828328907,0.2806761187038066,0,0,2.7172821676638472,4.762393939395157,MACF1;TMSB10
transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),2/133,0.1733172828328907,0.2806761187038066,0,0,2.7172821676638472,4.762393939395157,JUN;UBC
negative regulation of blood vessel endothelial cell migration (GO:0043537),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,HMGB1
regulation of activated T cell proliferation (GO:0046006),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,HMGB1
B cell receptor signaling pathway (GO:0050853),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,CD38
regulation of cell adhesion mediated by integrin (GO:0033628),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,DPP4
negative regulation of mitochondrion organization (GO:0010823),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,HUWE1
regulation of glucose metabolic process (GO:0010906),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,PMAIP1
central nervous system neuron differentiation (GO:0021953),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,SOX4
regulation of keratinocyte differentiation (GO:0045616),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,MACROH2A1
positive regulation of interleukin-12 production (GO:0032735),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,HMGB1
sister chromatid segregation (GO:0000819),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,TOP2A
positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,JUN
positive regulation of protein dephosphorylation (GO:0035307),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,PPIA
tRNA export from nucleus (GO:0006409),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,NUP214
tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),1/34,0.1753562518555918,0.2806761187038066,0,0,5.371753246753247,9.351876727319317,NUP214
positive regulation of cell differentiation (GO:0045597),3/258,0.17934217870249977,0.28555438477897327,0,0,2.0996791443850267,3.60821396123932,LEF1;MACROH2A1;FGFR1
negative regulation of Ras protein signal transduction (GO:0046580),1/35,0.18002341649109183,0.28555438477897327,0,0,5.213497899159663,8.93941981407905,STMN1
"nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",1/35,0.18002341649109183,0.28555438477897327,0,0,5.213497899159663,8.93941981407905,CNOT6
peptidyl-tyrosine dephosphorylation (GO:0035335),1/35,0.18002341649109183,0.28555438477897327,0,0,5.213497899159663,8.93941981407905,DUSP6
positive regulation of cell cycle G1/S phase transition (GO:1902808),1/35,0.18002341649109183,0.28555438477897327,0,0,5.213497899159663,8.93941981407905,CCND3
positive regulation of lymphocyte activation (GO:0051251),1/35,0.18002341649109183,0.28555438477897327,0,0,5.213497899159663,8.93941981407905,PRKDC
negative regulation of cellular protein localization (GO:1903828),1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,MACROH2A1
axonal transport (GO:0098930),1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,DYNC1H1
regulation of microtubule-based process (GO:0032886),1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,MACF1
regulation of osteoclast differentiation (GO:0045670),1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,CAMK4
embryonic limb morphogenesis (GO:0030326),1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,MBNL1
positive regulation of cytokine-mediated signaling pathway (GO:0001961),1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,CXCR4
retina homeostasis (GO:0001895),1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,ACTG1
intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,PMAIP1
positive regulation of myeloid leukocyte differentiation (GO:0002763),1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,LEF1
membrane assembly (GO:0071709),1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,SPTBN1
membrane fusion (GO:0061025),1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,HUWE1
positive regulation of telomere maintenance via telomere lengthening (GO:1904358),1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,HNRNPA1
"Wnt signaling pathway, calcium modulating pathway (GO:0007223)",1/36,0.1846643992267715,0.287316079973418,0,0,5.064285714285714,8.554668200781553,LEF1
negative regulation of stress-activated MAPK cascade (GO:0032873),1/37,0.18927934562097604,0.29149570257204166,0,0,4.923363095238095,8.195092150328568,PPIA
centromere complex assembly (GO:0034508),1/37,0.18927934562097604,0.29149570257204166,0,0,4.923363095238095,8.195092150328568,CENPF
regulation of microtubule cytoskeleton organization (GO:0070507),1/37,0.18927934562097604,0.29149570257204166,0,0,4.923363095238095,8.195092150328568,STMN1
"nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",1/37,0.18927934562097604,0.29149570257204166,0,0,4.923363095238095,8.195092150328568,UBC
regulation of transport (GO:0051049),1/37,0.18927934562097604,0.29149570257204166,0,0,4.923363095238095,8.195092150328568,ACTG1
regulation of vascular associated smooth muscle cell proliferation (GO:1904705),1/37,0.18927934562097604,0.29149570257204166,0,0,4.923363095238095,8.195092150328568,JUN
tRNA transport (GO:0051031),1/37,0.18927934562097604,0.29149570257204166,0,0,4.923363095238095,8.195092150328568,NUP214
regulation of protein phosphorylation (GO:0001932),3/266,0.19067110687790625,0.2932122544721291,0,0,2.034980988593156,3.372381256742085,CCND3;PRKDC;PPIA
central nervous system development (GO:0007417),3/268,0.19353200034895657,0.29343743596097016,0,0,2.019416809605489,3.31651327466565,UGP2;CXCR4;SOX4
actin-myosin filament sliding (GO:0033275),1/38,0.19386840050729504,0.29343743596097016,0,0,4.790057915057915,7.858452607463215,TPM4
negative regulation of endothelial cell migration (GO:0010596),1/38,0.19386840050729504,0.29343743596097016,0,0,4.790057915057915,7.858452607463215,HMGB1
regulation of apoptotic signaling pathway (GO:2001233),1/38,0.19386840050729504,0.29343743596097016,0,0,4.790057915057915,7.858452607463215,PPIA
regulation of axon extension (GO:0030516),1/38,0.19386840050729504,0.29343743596097016,0,0,4.790057915057915,7.858452607463215,MACF1
regulation of cell communication (GO:0010646),1/38,0.19386840050729504,0.29343743596097016,0,0,4.790057915057915,7.858452607463215,SOCS2
DNA replication initiation (GO:0006270),1/38,0.19386840050729504,0.29343743596097016,0,0,4.790057915057915,7.858452607463215,MCM7
positive regulation of insulin secretion (GO:0032024),1/38,0.19386840050729504,0.29343743596097016,0,0,4.790057915057915,7.858452607463215,SOX4
ventricular septum development (GO:0003281),1/38,0.19386840050729504,0.29343743596097016,0,0,4.790057915057915,7.858452607463215,SOX4
muscle filament sliding (GO:0030049),1/38,0.19386840050729504,0.29343743596097016,0,0,4.790057915057915,7.858452607463215,TPM4
ncRNA export from nucleus (GO:0097064),1/38,0.19386840050729504,0.29343743596097016,0,0,4.790057915057915,7.858452607463215,NUP214
positive regulation of cell migration (GO:0030335),3/269,0.19496655023455306,0.2946780144973673,0,0,2.0117224880382776,3.2890199601766423,LEF1;SYNE2;ACTG1
regulation of exit from mitosis (GO:0007096),1/39,0.19843170777529265,0.29694589367222013,0,0,4.663768796992481,7.542761216517415,UBC
"nucleotide-excision repair, DNA incision (GO:0033683)",1/39,0.19843170777529265,0.29694589367222013,0,0,4.663768796992481,7.542761216517415,UBC
endothelial cell migration (GO:0043542),1/39,0.19843170777529265,0.29694589367222013,0,0,4.663768796992481,7.542761216517415,DPP4
regulation of protein targeting to mitochondrion (GO:1903214),1/39,0.19843170777529265,0.29694589367222013,0,0,4.663768796992481,7.542761216517415,HUWE1
regulation of T cell differentiation (GO:0045580),1/39,0.19843170777529265,0.29694589367222013,0,0,4.663768796992481,7.542761216517415,CAMK4
replication fork processing (GO:0031297),1/39,0.19843170777529265,0.29694589367222013,0,0,4.663768796992481,7.542761216517415,NUCKS1
positive regulation of intracellular transport (GO:0032388),1/39,0.19843170777529265,0.29694589367222013,0,0,4.663768796992481,7.542761216517415,DYNC1H1
positive regulation of cytosolic calcium ion concentration (GO:0007204),2/147,0.20181642497466107,0.30075859444639674,0,0,2.45318421870146,3.9260681293429256,CXCR4;HMGB1
nucleocytoplasmic transport (GO:0006913),1/40,0.20296941061883486,0.30075859444639674,0,0,4.543956043956044,7.2462466937609475,HNRNPA1
regulation of microtubule polymerization (GO:0031113),1/40,0.20296941061883486,0.30075859444639674,0,0,4.543956043956044,7.2462466937609475,STMN1
positive regulation of double-strand break repair (GO:2000781),1/40,0.20296941061883486,0.30075859444639674,0,0,4.543956043956044,7.2462466937609475,PRKDC
positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),1/40,0.20296941061883486,0.30075859444639674,0,0,4.543956043956044,7.2462466937609475,PMAIP1
ribosomal small subunit biogenesis (GO:0042274),1/40,0.20296941061883486,0.30075859444639674,0,0,4.543956043956044,7.2462466937609475,RPS27
positive regulation of wound healing (GO:0090303),1/40,0.20296941061883486,0.30075859444639674,0,0,4.543956043956044,7.2462466937609475,ACTG1
regulation of cytosolic calcium ion concentration (GO:0051480),2/148,0.2038740261637798,0.30167653102276787,0,0,2.4362581759842032,3.8742668601875887,CXCR4;HMGB1
regulation of cell development (GO:0060284),1/41,0.20748165145642206,0.30403820947492316,0,0,4.430133928571428,6.967326429943189,HMGB2
regulation of mitochondrial membrane potential (GO:0051881),1/41,0.20748165145642206,0.30403820947492316,0,0,4.430133928571428,6.967326429943189,PMAIP1
regulation of protein dephosphorylation (GO:0035304),1/41,0.20748165145642206,0.30403820947492316,0,0,4.430133928571428,6.967326429943189,PPIA
epithelial cell migration (GO:0010631),1/41,0.20748165145642206,0.30403820947492316,0,0,4.430133928571428,6.967326429943189,DPP4
regulation of release of cytochrome c from mitochondria (GO:0090199),1/41,0.20748165145642206,0.30403820947492316,0,0,4.430133928571428,6.967326429943189,PMAIP1
regulation of response to DNA damage stimulus (GO:2001020),1/41,0.20748165145642206,0.30403820947492316,0,0,4.430133928571428,6.967326429943189,USP1
JNK cascade (GO:0007254),1/41,0.20748165145642206,0.30403820947492316,0,0,4.430133928571428,6.967326429943189,UBC
response to cytokine (GO:0034097),2/150,0.20799637928582237,0.3043709118733057,0,0,2.4030922814706597,3.7734186634877904,LEF1;CXCR4
regulation of double-strand break repair (GO:2000779),1/42,0.21196857185865262,0.3063698757192001,0,0,4.3218641114982574,6.704582396941519,DEK
regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),1/42,0.21196857185865262,0.3063698757192001,0,0,4.3218641114982574,6.704582396941519,PMAIP1
regulation of nervous system development (GO:0051960),1/42,0.21196857185865262,0.3063698757192001,0,0,4.3218641114982574,6.704582396941519,HMGB2
phosphatidylinositol phosphate biosynthetic process (GO:0046854),1/42,0.21196857185865262,0.3063698757192001,0,0,4.3218641114982574,6.704582396941519,SOCS2
positive regulation of ATPase activity (GO:0032781),1/42,0.21196857185865262,0.3063698757192001,0,0,4.3218641114982574,6.704582396941519,HNRNPU
positive regulation of epithelial to mesenchymal transition (GO:0010718),1/42,0.21196857185865262,0.3063698757192001,0,0,4.3218641114982574,6.704582396941519,LEF1
histone H3 acetylation (GO:0043966),1/42,0.21196857185865262,0.3063698757192001,0,0,4.3218641114982574,6.704582396941519,LEF1
skeletal system morphogenesis (GO:0048705),1/42,0.21196857185865262,0.3063698757192001,0,0,4.3218641114982574,6.704582396941519,FGFR1
translesion synthesis (GO:0019985),1/42,0.21196857185865262,0.3063698757192001,0,0,4.3218641114982574,6.704582396941519,UBC
positive regulation of Wnt signaling pathway (GO:0030177),2/153,0.21419642122711408,0.30777321343325886,0,0,2.3549907523417457,3.6287153572984754,MACF1;SOX4
regulation of carbohydrate catabolic process (GO:0043470),1/43,0.21643031266006105,0.30777321343325886,0,0,4.21875,6.456740617261403,NUP214
regulation of cell-cell adhesion (GO:0022407),1/43,0.21643031266006105,0.30777321343325886,0,0,4.21875,6.456740617261403,DPP4
development of primary male sexual characteristics (GO:0046546),1/43,0.21643031266006105,0.30777321343325886,0,0,4.21875,6.456740617261403,CSDE1
DNA synthesis involved in DNA repair (GO:0000731),1/43,0.21643031266006105,0.30777321343325886,0,0,4.21875,6.456740617261403,UBC
DNA-dependent DNA replication maintenance of fidelity (GO:0045005),1/43,0.21643031266006105,0.30777321343325886,0,0,4.21875,6.456740617261403,NUCKS1
regulation of purine nucleotide metabolic process (GO:1900542),1/43,0.21643031266006105,0.30777321343325886,0,0,4.21875,6.456740617261403,NUP214
positive regulation of axonogenesis (GO:0050772),1/43,0.21643031266006105,0.30777321343325886,0,0,4.21875,6.456740617261403,MACF1
positive regulation of neuron differentiation (GO:0045666),1/43,0.21643031266006105,0.30777321343325886,0,0,4.21875,6.456740617261403,FGFR1
positive regulation of peptide hormone secretion (GO:0090277),1/43,0.21643031266006105,0.30777321343325886,0,0,4.21875,6.456740617261403,SOX4
positive regulation of phospholipase C activity (GO:0010863),1/43,0.21643031266006105,0.30777321343325886,0,0,4.21875,6.456740617261403,FGFR1
male gonad development (GO:0008584),1/43,0.21643031266006105,0.30777321343325886,0,0,4.21875,6.456740617261403,CSDE1
positive regulation of NF-kappaB transcription factor activity (GO:0051092),2/155,0.21833975118240148,0.3100717540281621,0,0,2.3239710298533827,3.5363935433004756,UBC;PPIA
regulation of cell differentiation (GO:0045595),2/156,0.22041414494525816,0.3111548611295461,0,0,2.3087633087633086,3.491420445672637,NREP;FGFR1
peptidyl-serine phosphorylation (GO:0018105),2/156,0.22041414494525816,0.3111548611295461,0,0,2.3087633087633086,3.491420445672637,PRKDC;CAMK4
cardiac ventricle morphogenesis (GO:0003208),1/44,0.2208670139019746,0.3111548611295461,0,0,4.120431893687708,6.222653606697369,SOX4
neurogenesis (GO:0022008),1/44,0.2208670139019746,0.3111548611295461,0,0,4.120431893687708,6.222653606697369,CXCR4
positive regulation of mRNA catabolic process (GO:0061014),1/44,0.2208670139019746,0.3111548611295461,0,0,4.120431893687708,6.222653606697369,BTG2
mRNA stabilization (GO:0048255),1/44,0.2208670139019746,0.3111548611295461,0,0,4.120431893687708,6.222653606697369,HNRNPU
cellular response to starvation (GO:0009267),2/158,0.22456796273954596,0.3152711456369878,0,0,2.278932778932779,3.403761328514447,PMAIP1;HNRNPA1
skeletal system development (GO:0001501),2/158,0.22456796273954596,0.3152711456369878,0,0,2.278932778932779,3.403761328514447,SOX4;FGFR1
negative regulation of T cell activation (GO:0050868),1/45,0.22527881484079657,0.3152711456369878,0,0,4.026582792207792,6.001285298656355,PAG1
regulation of insulin receptor signaling pathway (GO:0046626),1/45,0.22527881484079657,0.3152711456369878,0,0,4.026582792207792,6.001285298656355,NUCKS1
regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),1/45,0.22527881484079657,0.3152711456369878,0,0,4.026582792207792,6.001285298656355,JUN
response to lipopolysaccharide (GO:0032496),2/159,0.22664721849366415,0.3163492838605497,0,0,2.2643025190795893,3.3610413867595272,HMGB2;HMGB1
protein autophosphorylation (GO:0046777),2/159,0.22664721849366415,0.3163492838605497,0,0,2.2643025190795893,3.3610413867595272,CAMK4;FGFR1
regulation of B cell proliferation (GO:0030888),1/46,0.22966585404452466,0.3188798865867547,0,0,3.9369047619047617,5.791698052439392,CD38
interleukin-12-mediated signaling pathway (GO:0035722),1/46,0.22966585404452466,0.3188798865867547,0,0,3.9369047619047617,5.791698052439392,PPIA
positive regulation of smooth muscle cell proliferation (GO:0048661),1/46,0.22966585404452466,0.3188798865867547,0,0,3.9369047619047617,5.791698052439392,JUN
postreplication repair (GO:0006301),1/46,0.22966585404452466,0.3188798865867547,0,0,3.9369047619047617,5.791698052439392,UBC
positive regulation of protein kinase B signaling (GO:0051897),2/161,0.23081000976743413,0.3200484801231262,0,0,2.2355940846506885,3.2777394624212106,GAB2;FGFR1
peptide biosynthetic process (GO:0043043),2/162,0.23289338226900685,0.32209306985700553,0,0,2.221509009009009,3.237126317146171,RPS27;RPL21
rRNA metabolic process (GO:0016072),2/162,0.23289338226900685,0.32209306985700553,0,0,2.221509009009009,3.237126317146171,RPS27;RPL21
regulation of T cell activation (GO:0050863),1/47,0.23402826916338243,0.3223983187172638,0,0,3.8511257763975157,5.5930414258483685,PAG1
regulation of wound healing (GO:0061041),1/47,0.23402826916338243,0.3223983187172638,0,0,3.8511257763975157,5.5930414258483685,ACTG1
telomere organization (GO:0032200),1/47,0.23402826916338243,0.3223983187172638,0,0,3.8511257763975157,5.5930414258483685,PRKDC
base-excision repair (GO:0006284),1/48,0.23836619727956293,0.3245707036316314,0,0,3.768996960486322,5.404542426400358,HUWE1
negative regulation of mitotic cell cycle (GO:0045930),1/48,0.23836619727956293,0.3245707036316314,0,0,3.768996960486322,5.404542426400358,BTG2
cellular response to interleukin-12 (GO:0071349),1/48,0.23836619727956293,0.3245707036316314,0,0,3.768996960486322,5.404542426400358,PPIA
cellular response to ionizing radiation (GO:0071479),1/48,0.23836619727956293,0.3245707036316314,0,0,3.768996960486322,5.404542426400358,NUCKS1
regulation of interleukin-10 production (GO:0032653),1/48,0.23836619727956293,0.3245707036316314,0,0,3.768996960486322,5.404542426400358,HMGB1
regulation of interleukin-2 production (GO:0032663),1/48,0.23836619727956293,0.3245707036316314,0,0,3.768996960486322,5.404542426400358,SPTBN1
positive regulation of DNA repair (GO:0045739),1/48,0.23836619727956293,0.3245707036316314,0,0,3.768996960486322,5.404542426400358,HMGB1
histone H4 acetylation (GO:0043967),1/48,0.23836619727956293,0.3245707036316314,0,0,3.768996960486322,5.404542426400358,LEF1
myelination (GO:0042552),1/48,0.23836619727956293,0.3245707036316314,0,0,3.768996960486322,5.404542426400358,CXCR4
regulation of MAPK cascade (GO:0043408),2/166,0.24123818944823663,0.328059131666111,0,0,2.1668863985937157,3.081248526152713,HMGB1;FGFR1
regulation of cellular localization (GO:0060341),1/49,0.2426797745527419,0.3287518584850204,0,0,3.6902901785714284,5.225497039560622,DYNC1H1
regulation of smooth muscle cell proliferation (GO:0048660),1/49,0.2426797745527419,0.3287518584850204,0,0,3.6902901785714284,5.225497039560622,PRKDC
regulation of stress-activated MAPK cascade (GO:0032872),1/49,0.2426797745527419,0.3287518584850204,0,0,3.6902901785714284,5.225497039560622,PPIA
innate immune response (GO:0045087),3/302,0.24360761561407657,0.3295867740661036,0,0,1.7866828823350562,2.5231472788311815,H2BC21;H2BC11;HMGB1
negative regulation of ERK1 and ERK2 cascade (GO:0070373),1/50,0.2469691364760274,0.3320118759741258,0,0,3.614795918367347,5.055262825364014,DUSP6
regulation of generation of precursor metabolites and energy (GO:0043467),1/50,0.2469691364760274,0.3320118759741258,0,0,3.614795918367347,5.055262825364014,NUP214
neuron migration (GO:0001764),1/50,0.2469691364760274,0.3320118759741258,0,0,3.614795918367347,5.055262825364014,FGFR1
positive regulation of cell morphogenesis involved in differentiation (GO:0010770),1/50,0.2469691364760274,0.3320118759741258,0,0,3.614795918367347,5.055262825364014,PRKDC
ribosome assembly (GO:0042255),1/50,0.2469691364760274,0.3320118759741258,0,0,3.614795918367347,5.055262825364014,RPS27
peptidyl-serine modification (GO:0018209),2/169,0.24750650252535655,0.3323120300403899,0,0,2.1276366186545825,2.9708582112444306,PRKDC;CAMK4
regulation of epithelial cell migration (GO:0010632),1/51,0.25123441778349326,0.33476827961578826,0,0,3.5423214285714284,4.893252443770648,MACF1
negative regulation of protein ubiquitination (GO:0031397),1/51,0.25123441778349326,0.33476827961578826,0,0,3.5423214285714284,4.893252443770648,SOX4
regulation of interleukin-12 production (GO:0032655),1/51,0.25123441778349326,0.33476827961578826,0,0,3.5423214285714284,4.893252443770648,HMGB1
positive regulation of fat cell differentiation (GO:0045600),1/51,0.25123441778349326,0.33476827961578826,0,0,3.5423214285714284,4.893252443770648,HNRNPU
gonad development (GO:0008406),1/51,0.25123441778349326,0.33476827961578826,0,0,3.5423214285714284,4.893252443770648,CSDE1
intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),1/51,0.25123441778349326,0.33476827961578826,0,0,3.5423214285714284,4.893252443770648,PRKDC
negative regulation of protein-containing complex assembly (GO:0031333),1/52,0.255475752456584,0.33786668262383235,0,0,3.472689075630252,4.738927970587911,HMGB1
regulation of intrinsic apoptotic signaling pathway (GO:2001242),1/52,0.255475752456584,0.33786668262383235,0,0,3.472689075630252,4.738927970587911,PMAIP1
endocytic recycling (GO:0032456),1/52,0.255475752456584,0.33786668262383235,0,0,3.472689075630252,4.738927970587911,ARL4C
positive regulation of developmental growth (GO:0048639),1/52,0.255475752456584,0.33786668262383235,0,0,3.472689075630252,4.738927970587911,MACF1
positive regulation of protein localization to cell periphery (GO:1904377),1/52,0.255475752456584,0.33786668262383235,0,0,3.472689075630252,4.738927970587911,SPTBN1
positive regulation of protein localization to plasma membrane (GO:1903078),1/52,0.255475752456584,0.33786668262383235,0,0,3.472689075630252,4.738927970587911,SPTBN1
regulation of DNA replication (GO:0006275),1/53,0.2596932737449941,0.3421612498408515,0,0,3.40573489010989,4.591795895412046,NUCKS1
positive regulation of B cell activation (GO:0050871),1/53,0.2596932737449941,0.3421612498408515,0,0,3.40573489010989,4.591795895412046,CD38
positive regulation of chemokine production (GO:0032722),1/53,0.2596932737449941,0.3421612498408515,0,0,3.40573489010989,4.591795895412046,HMGB1
cellular macromolecule biosynthetic process (GO:0034645),3/314,0.26178262753382253,0.3444850994163983,0,0,1.7166910260157848,2.30077932914368,RPS27;RPL21;MCM7
regulation of cyclin-dependent protein kinase activity (GO:1904029),1/54,0.2638871142135861,0.3455353549974927,0,0,3.341307277628032,4.451402708485304,CCND3
regulation of megakaryocyte differentiation (GO:0045652),1/54,0.2638871142135861,0.3455353549974927,0,0,3.341307277628032,4.451402708485304,HMGB2
cytoplasmic microtubule organization (GO:0031122),1/54,0.2638871142135861,0.3455353549974927,0,0,3.341307277628032,4.451402708485304,DYNC1H1
positive regulation of leukocyte chemotaxis (GO:0002690),1/54,0.2638871142135861,0.3455353549974927,0,0,3.341307277628032,4.451402708485304,HMGB1
protein sumoylation (GO:0016925),1/55,0.26805740556347285,0.348408765462106,0,0,3.279265873015873,4.317331000761209,NUP214
negative regulation of cytokine-mediated signaling pathway (GO:0001960),1/55,0.26805740556347285,0.348408765462106,0,0,3.279265873015873,4.317331000761209,H2BC11
negative regulation of protein modification by small protein conjugation or removal (GO:1903321),1/55,0.26805740556347285,0.348408765462106,0,0,3.279265873015873,4.317331000761209,SOX4
regulation of gene silencing by RNA (GO:0060966),1/55,0.26805740556347285,0.348408765462106,0,0,3.279265873015873,4.317331000761209,NUP214
regulation of posttranscriptional gene silencing (GO:0060147),1/55,0.26805740556347285,0.348408765462106,0,0,3.279265873015873,4.317331000761209,NUP214
positive regulation of response to DNA damage stimulus (GO:2001022),1/55,0.26805740556347285,0.348408765462106,0,0,3.279265873015873,4.317331000761209,PMAIP1
protein stabilization (GO:0050821),2/179,0.26843370540780126,0.3484697672655874,0,0,2.006413192853871,2.6387369244432604,H1-5;SOX4
positive regulation of cellular biosynthetic process (GO:0031328),2/180,0.2705273940915964,0.3503553857234328,0,0,1.9950399838040287,2.6082791920646264,PRKDC;SOX4
regulation of ATP metabolic process (GO:1903578),1/56,0.27220427888909426,0.3503553857234328,0,0,3.2194805194805194,4.189196001608424,NUP214
"nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",1/56,0.27220427888909426,0.3503553857234328,0,0,3.2194805194805194,4.189196001608424,CNOT6
peptidyl-tyrosine modification (GO:0018212),1/56,0.27220427888909426,0.3503553857234328,0,0,3.2194805194805194,4.189196001608424,FGFR1
telomere maintenance (GO:0000723),1/56,0.27220427888909426,0.3503553857234328,0,0,3.2194805194805194,4.189196001608424,PRKDC
tight junction assembly (GO:0120192),1/56,0.27220427888909426,0.3503553857234328,0,0,3.2194805194805194,4.189196001608424,ACTG1
mitochondrial transport (GO:0006839),1/56,0.27220427888909426,0.3503553857234328,0,0,3.2194805194805194,4.189196001608424,PMAIP1
negative regulation of cytokine production (GO:0001818),2/182,0.2747144230388638,0.35315657299528297,0,0,1.9726726726726727,2.5487388247101594,LEF1;HMGB1
negative regulation of cell cycle G2/M phase transition (GO:1902750),1/57,0.2763278645455049,0.35394053352196636,0,0,3.161830357142857,4.066642507622085,MACROH2A1
regulation of mitotic nuclear division (GO:0007088),1/57,0.2763278645455049,0.35394053352196636,0,0,3.161830357142857,4.066642507622085,MKI67
renal system development (GO:0072001),1/57,0.2763278645455049,0.35394053352196636,0,0,3.161830357142857,4.066642507622085,CENPF
regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),1/58,0.28042829211387854,0.3577505770295119,0,0,3.106203007518797,3.949342147043287,H2BC11
positive regulation of mitochondrion organization (GO:0010822),1/58,0.28042829211387854,0.3577505770295119,0,0,3.106203007518797,3.949342147043287,PMAIP1
positive regulation of mitotic cell cycle phase transition (GO:1901992),1/58,0.28042829211387854,0.3577505770295119,0,0,3.106203007518797,3.949342147043287,CCND3
antigen receptor-mediated signaling pathway (GO:0050851),2/185,0.28099312808272625,0.3577505770295119,0,0,1.9400383990547925,2.46273337115057,CD38;PAG1
endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),2/185,0.28099312808272625,0.3577505770295119,0,0,1.9400383990547925,2.46273337115057,DYNC1H1;SPTBN1
positive regulation of apoptotic signaling pathway (GO:2001235),1/59,0.2845056905022261,0.3609196889104979,0,0,3.052493842364532,3.836990937643376,PMAIP1
response to reactive oxygen species (GO:0000302),1/59,0.2845056905022261,0.3609196889104979,0,0,3.052493842364532,3.836990937643376,JUN
mitotic DNA damage checkpoint signaling (GO:0044773),1/59,0.2845056905022261,0.3609196889104979,0,0,3.052493842364532,3.836990937643376,PRKDC
peptidyl-threonine phosphorylation (GO:0018107),1/60,0.28856018790506505,0.36562476503420216,0,0,3.000605326876513,3.729307105087004,PRKDC
B cell differentiation (GO:0030183),1/61,0.2925919118076534,0.3689657243057179,0,0,2.9504464285714285,3.6260291283322426,RAG1
positive regulation of DNA biosynthetic process (GO:2000573),1/61,0.2925919118076534,0.3689657243057179,0,0,2.9504464285714285,3.6260291283322426,HNRNPA1
response to light stimulus (GO:0009416),1/61,0.2925919118076534,0.3689657243057179,0,0,2.9504464285714285,3.6260291283322426,USP1
positive regulation of interleukin-8 production (GO:0032757),1/61,0.2925919118076534,0.3689657243057179,0,0,2.9504464285714285,3.6260291283322426,HMGB1
negative regulation of cell differentiation (GO:0045596),2/191,0.2935377481825512,0.36971778282992757,0,0,1.877877877877878,2.3018069949180444,MYB;HNRNPU
positive regulation of cytokine production (GO:0001819),3/335,0.2939731949772938,0.3698259694244671,0,0,1.6063800657174152,1.966637604888291,PRKDC;HMGB1;SPTBN1
ribosome biogenesis (GO:0042254),2/192,0.29562615734638636,0.3709265323437204,0,0,1.8678994784257943,2.27633364024021,RPS27;RPL21
regulation of neurogenesis (GO:0050767),1/62,0.29660098900074433,0.3709265323437204,0,0,2.9019320843091334,3.5269139854953258,HMGB2
positive regulation of interleukin-1 production (GO:0032732),1/62,0.29660098900074433,0.3709265323437204,0,0,2.9019320843091334,3.5269139854953258,HMGB1
I-kappaB kinase/NF-kappaB signaling (GO:0007249),1/62,0.29660098900074433,0.3709265323437204,0,0,2.9019320843091334,3.5269139854953258,UBC
stress-activated MAPK cascade (GO:0051403),1/62,0.29660098900074433,0.3709265323437204,0,0,2.9019320843091334,3.5269139854953258,UBC
amyloid fibril formation (GO:1990000),1/63,0.30058754552532485,0.37370343497743086,0,0,2.8549827188940093,3.431735577536177,UBC
cellular response to reactive oxygen species (GO:0034614),1/63,0.30058754552532485,0.37370343497743086,0,0,2.8549827188940093,3.431735577536177,JUN
organonitrogen compound catabolic process (GO:1901565),1/63,0.30058754552532485,0.37370343497743086,0,0,2.8549827188940093,3.431735577536177,ERAP2
positive regulation of DNA metabolic process (GO:0051054),1/63,0.30058754552532485,0.37370343497743086,0,0,2.8549827188940093,3.431735577536177,HMGB1
positive regulation of viral process (GO:0048524),1/63,0.30058754552532485,0.37370343497743086,0,0,2.8549827188940093,3.431735577536177,PPIA
negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),1/64,0.30455170681485055,0.3768604746317098,0,0,2.8095238095238093,3.340283306790809,PPIA
regulation of extrinsic apoptotic signaling pathway (GO:2001236),1/64,0.30455170681485055,0.3768604746317098,0,0,2.8095238095238093,3.340283306790809,FGFR1
regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),1/64,0.30455170681485055,0.3768604746317098,0,0,2.8095238095238093,3.340283306790809,LEF1
protein catabolic process (GO:0030163),1/64,0.30455170681485055,0.3768604746317098,0,0,2.8095238095238093,3.340283306790809,PMAIP1
protein autoubiquitination (GO:0051865),1/65,0.3084935975362333,0.38129232031931637,0,0,2.7654854910714284,3.252360797447699,RAG1
endomembrane system organization (GO:0010256),2/199,0.3102186363031123,0.3829770329156275,0,0,1.8008871815978416,2.1078987395553574,HUWE1;SPTBN1
cell-cell junction assembly (GO:0007043),1/66,0.3124133416468328,0.3843410644911036,0,0,2.722802197802198,3.167784737398363,ACTG1
positive regulation of cell cycle (GO:0045787),1/66,0.3124133416468328,0.3843410644911036,0,0,2.722802197802198,3.167784737398363,CCND3
positive regulation of T cell proliferation (GO:0042102),1/66,0.3124133416468328,0.3843410644911036,0,0,2.722802197802198,3.167784737398363,HMGB1
ncRNA processing (GO:0034470),2/201,0.3143777922795721,0.38630859957234287,0,0,1.7826067273303454,2.0627609441962784,RPS27;RPL21
regulation of gene silencing by miRNA (GO:0060964),1/67,0.31631106257055025,0.38661643430662246,0,0,2.6814123376623376,3.086383829115508,NUP214
peptidyl-threonine modification (GO:0018210),1/67,0.31631106257055025,0.38661643430662246,0,0,2.6814123376623376,3.086383829115508,PRKDC
positive regulation of catabolic process (GO:0009896),1/67,0.31631106257055025,0.38661643430662246,0,0,2.6814123376623376,3.086383829115508,HUWE1
regulation of viral genome replication (GO:0045069),1/67,0.31631106257055025,0.38661643430662246,0,0,2.6814123376623376,3.086383829115508,PPIA
generation of neurons (GO:0048699),2/202,0.3164554178729065,0.38661643430662246,0,0,1.7736036036036036,2.040660254278166,HMGB2;FGFR1
canonical Wnt signaling pathway (GO:0060070),1/68,0.32018688283567626,0.3898247664443561,0,0,2.6412579957356077,3.007997843258375,LEF1
negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),1/68,0.32018688283567626,0.3898247664443561,0,0,2.6412579957356077,3.007997843258375,UBC
regulation of translational initiation (GO:0006446),1/68,0.32018688283567626,0.3898247664443561,0,0,2.6412579957356077,3.007997843258375,CSDE1
proteasomal protein catabolic process (GO:0010498),2/205,0.32267987336919846,0.3918117692931258,0,0,1.7471264367816093,1.9761651931598212,HUWE1;PMAIP1
cellular response to decreased oxygen levels (GO:0036294),1/69,0.3240409245099103,0.3918117692931258,0,0,2.602284663865546,2.93247675296454,PMAIP1
peptidyl-tyrosine phosphorylation (GO:0018108),1/69,0.3240409245099103,0.3918117692931258,0,0,2.602284663865546,2.93247675296454,FGFR1
RNA 3'-end processing (GO:0031123),1/69,0.3240409245099103,0.3918117692931258,0,0,2.602284663865546,2.93247675296454,SRSF3
positive regulation of MAP kinase activity (GO:0043406),1/69,0.3240409245099103,0.3918117692931258,0,0,2.602284663865546,2.93247675296454,FGFR1
positive regulation of protein transport (GO:0051222),1/69,0.3240409245099103,0.3918117692931258,0,0,2.602284663865546,2.93247675296454,PPIA
regulation of protein kinase B signaling (GO:0051896),2/207,0.326821994679401,0.39419313715930526,0,0,1.729905515271369,1.9346218680742258,GAB2;FGFR1
carbohydrate homeostasis (GO:0033500),1/70,0.32787330879034837,0.39419313715930526,0,0,2.56444099378882,2.8596799537037407,SOX4
negative regulation of viral process (GO:0048525),1/70,0.32787330879034837,0.39419313715930526,0,0,2.56444099378882,2.8596799537037407,PPIA
neutrophil chemotaxis (GO:0030593),1/70,0.32787330879034837,0.39419313715930526,0,0,2.56444099378882,2.8596799537037407,PPIA
wound healing (GO:0042060),1/70,0.32787330879034837,0.39419313715930526,0,0,2.56444099378882,2.8596799537037407,MACF1
negative regulation of neuron apoptotic process (GO:0043524),1/71,0.33168415636703996,0.3965218502105404,0,0,2.5276785714285714,2.7894755469645713,NONO
regulation of G1/S transition of mitotic cell cycle (GO:2000045),1/71,0.33168415636703996,0.3965218502105404,0,0,2.5276785714285714,2.7894755469645713,CCND3
regulation of glycolytic process (GO:0006110),1/71,0.33168415636703996,0.3965218502105404,0,0,2.5276785714285714,2.7894755469645713,NUP214
Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),1/71,0.33168415636703996,0.3965218502105404,0,0,2.5276785714285714,2.7894755469645713,ACTG1
histone acetylation (GO:0016573),1/71,0.33168415636703996,0.3965218502105404,0,0,2.5276785714285714,2.7894755469645713,LEF1
cell junction organization (GO:0034330),1/72,0.33547358712078257,0.3992475311291203,0,0,2.4919517102615694,2.721739692400628,ACTG1
negative regulation of supramolecular fiber organization (GO:1902904),1/72,0.33547358712078257,0.3992475311291203,0,0,2.4919517102615694,2.721739692400628,STMN1
Fc-gamma receptor signaling pathway (GO:0038094),1/72,0.33547358712078257,0.3992475311291203,0,0,2.4919517102615694,2.721739692400628,ACTG1
positive regulation of secretion by cell (GO:1903532),1/72,0.33547358712078257,0.3992475311291203,0,0,2.4919517102615694,2.721739692400628,PPIA
regulation of Rho protein signal transduction (GO:0035023),1/73,0.33924172042330947,0.4014739823354155,0,0,2.457217261904762,2.6563560119679144,STMN1
granulocyte chemotaxis (GO:0071621),1/73,0.33924172042330947,0.4014739823354155,0,0,2.457217261904762,2.6563560119679144,PPIA
response to molecule of bacterial origin (GO:0002237),1/73,0.33924172042330947,0.4014739823354155,0,0,2.457217261904762,2.6563560119679144,HMGB2
positive regulation of JNK cascade (GO:0046330),1/73,0.33924172042330947,0.4014739823354155,0,0,2.457217261904762,2.6563560119679144,HMGB1
transcription-coupled nucleotide-excision repair (GO:0006283),1/73,0.33924172042330947,0.4014739823354155,0,0,2.457217261904762,2.6563560119679144,UBC
positive regulation of protein modification process (GO:0031401),2/214,0.3412660390818255,0.402968157755102,0,0,1.6721910589835118,1.7977607894953271,CCND3;PPIA
translation (GO:0006412),2/214,0.3412660390818255,0.402968157755102,0,0,1.6721910589835118,1.7977607894953271,RPS27;RPL21
regulation of peptide hormone secretion (GO:0090276),1/74,0.34298867484108103,0.40410024274149636,0,0,2.4234344422700587,2.593215049680486,DPP4
Fc receptor mediated stimulatory signaling pathway (GO:0002431),1/74,0.34298867484108103,0.40410024274149636,0,0,2.4234344422700587,2.593215049680486,ACTG1
nucleic acid phosphodiester bond hydrolysis (GO:0090305),1/75,0.3467145684244282,0.4066785070876331,0,0,2.390564671814672,2.532213773065932,UBC
regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),1/75,0.3467145684244282,0.4066785070876331,0,0,2.390564671814672,2.532213773065932,UBC
positive regulation of immune response (GO:0050778),1/75,0.3467145684244282,0.4066785070876331,0,0,2.390564671814672,2.532213773065932,MYB
positive regulation of lymphocyte proliferation (GO:0050671),1/75,0.3467145684244282,0.4066785070876331,0,0,2.390564671814672,2.532213773065932,CD38
regulation of cell growth (GO:0001558),2/217,0.3474281818910229,0.4070642485500579,0,0,1.6486067462811649,1.7429026110755057,SOCS2;H1-5
regulation of epithelial to mesenchymal transition (GO:0010717),1/76,0.35041951847332065,0.40785902150140074,0,0,2.3585714285714285,2.473255120037774,LEF1
cellular response to hormone stimulus (GO:0032870),1/76,0.35041951847332065,0.40785902150140074,0,0,2.3585714285714285,2.473255120037774,SOCS2
establishment of protein localization to organelle (GO:0072594),1/76,0.35041951847332065,0.40785902150140074,0,0,2.3585714285714285,2.473255120037774,NUP214
positive regulation of growth (GO:0045927),1/76,0.35041951847332065,0.40785902150140074,0,0,2.3585714285714285,2.473255120037774,H1-5
positive regulation of interleukin-6 production (GO:0032755),1/76,0.35041951847332065,0.40785902150140074,0,0,2.3585714285714285,2.473255120037774,HMGB1
protein import into nucleus (GO:0006606),1/76,0.35041951847332065,0.40785902150140074,0,0,2.3585714285714285,2.473255120037774,NUP214
negative regulation of developmental process (GO:0051093),1/77,0.35410364162030483,0.4094444293270847,0,0,2.327420112781955,2.416247581065218,HUWE1
neutrophil migration (GO:1990266),1/77,0.35410364162030483,0.4094444293270847,0,0,2.327420112781955,2.416247581065218,PPIA
positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),1/77,0.35410364162030483,0.4094444293270847,0,0,2.327420112781955,2.416247581065218,FGFR1
positive regulation of protein modification by small protein conjugation or removal (GO:1903322),1/77,0.35410364162030483,0.4094444293270847,0,0,2.327420112781955,2.416247581065218,HUWE1
positive regulation of tumor necrosis factor production (GO:0032760),1/77,0.35410364162030483,0.4094444293270847,0,0,2.327420112781955,2.416247581065218,HMGB1
positive regulation of type I interferon production (GO:0032481),1/77,0.35410364162030483,0.4094444293270847,0,0,2.327420112781955,2.416247581065218,PRKDC
protein modification process (GO:0036211),1/78,0.3577670539335288,0.412778127657223,0,0,2.2970779220779223,2.3611048153655285,PRKDC
negative regulation of protein serine/threonine kinase activity (GO:0071901),1/78,0.3577670539335288,0.412778127657223,0,0,2.2970779220779223,2.3611048153655285,MACROH2A1
recombinational repair (GO:0000725),1/79,0.36140987082557346,0.41517007962373154,0,0,2.2675137362637363,2.3077452992984555,NUCKS1
axon development (GO:0061564),1/79,0.36140987082557346,0.41517007962373154,0,0,2.2675137362637363,2.3077452992984555,NREP
regulation of cellular response to heat (GO:1900034),1/79,0.36140987082557346,0.41517007962373154,0,0,2.2675137362637363,2.3077452992984555,NUP214
mRNA 3'-end processing (GO:0031124),1/79,0.36140987082557346,0.41517007962373154,0,0,2.2675137362637363,2.3077452992984555,SRSF3
negative regulation of cell population proliferation (GO:0008285),3/379,0.3619725874590134,0.4153655070842041,0,0,1.415207930367505,1.438115611407937,BTG2;H2AC6;SOX4
negative regulation of cell cycle (GO:0045786),1/80,0.3650322070290576,0.41751791895864104,0,0,2.2386980108499097,2.2560920023156177,BTG2
regulation of protein localization to plasma membrane (GO:1903076),1/80,0.3650322070290576,0.41751791895864104,0,0,2.2386980108499097,2.2560920023156177,SPTBN1
skin development (GO:0043588),1/80,0.3650322070290576,0.41751791895864104,0,0,2.2386980108499097,2.2560920023156177,STMN1
regulation of interleukin-8 production (GO:0032677),1/81,0.36863417667507764,0.4207281110272192,0,0,2.2106026785714286,2.206072087773048,HMGB1
positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),1/81,0.36863417667507764,0.4207281110272192,0,0,2.2106026785714286,2.206072087773048,HMGB1
positive regulation of intracellular signal transduction (GO:1902533),4/546,0.37206808831609284,0.4225369260447851,0,0,1.309793831883273,1.2949648809726477,PMAIP1;HMGB1;GAB2;FGFR1
regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),1/82,0.3722158932644043,0.4225369260447851,0,0,2.183201058201058,2.1576166376462975,CCND3
ephrin receptor signaling pathway (GO:0048013),1/82,0.3722158932644043,0.4225369260447851,0,0,2.183201058201058,2.1576166376462975,ACTG1
positive regulation of cytoskeleton organization (GO:0051495),1/82,0.3722158932644043,0.4225369260447851,0,0,2.183201058201058,2.1576166376462975,DYNC1H1
positive regulation of protein ubiquitination (GO:0031398),1/82,0.3722158932644043,0.4225369260447851,0,0,2.183201058201058,2.1576166376462975,HUWE1
inflammatory response (GO:0006954),2/230,0.373901824387847,0.42399585230690473,0,0,1.5535798956851588,1.528352892781401,CXCR4;HMGB1
peptide metabolic process (GO:0006518),1/83,0.3757774696582015,0.4256665555657143,0,0,2.156467770034843,2.1106603982585272,ERAP2
anaphase-promoting complex-dependent catabolic process (GO:0031145),1/84,0.37931901811137053,0.4287601721814423,0,0,2.1303786574870913,2.0651415450573505,UBC
response to insulin (GO:0032868),1/84,0.37931901811137053,0.4287601721814423,0,0,2.1303786574870913,2.0651415450573505,PRKDC
B cell activation (GO:0042113),1/85,0.38284065023709285,0.43135826192848165,0,0,2.1049107142857144,2.0210014654173967,RAG1
G1/S transition of mitotic cell cycle (GO:0000082),1/85,0.38284065023709285,0.43135826192848165,0,0,2.1049107142857144,2.0210014654173967,TFDP2
positive regulation of protein catabolic process (GO:0045732),1/85,0.38284065023709285,0.43135826192848165,0,0,2.1049107142857144,2.0210014654173967,HUWE1
negative regulation of cellular amide metabolic process (GO:0034249),1/86,0.3863424770334258,0.434378682998262,0,0,2.080042016806723,1.9781845571969963,BTG2
regulation of interferon-gamma production (GO:0032649),1/86,0.3863424770334258,0.434378682998262,0,0,2.080042016806723,1.9781845571969963,HMGB1
regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),1/87,0.3898246089065554,0.4375414859061308,0,0,2.0557516611295683,1.9366380420805769,UBC
regulation of ERK1 and ERK2 cascade (GO:0070372),2/238,0.3899826287424209,0.4375414859061308,0,0,1.5003053901358987,1.4127671953676786,HMGB1;DUSP6
phosphorylation (GO:0016310),3/400,0.3942041828743113,0.4418093490265057,0,0,1.338905427066636,1.2463686832682195,PRKDC;CAMK4;FGFR1
regulation of cation channel activity (GO:2001257),1/89,0.3967302263993966,0.44276432439932656,0,0,2.0088271103896105,1.8571581721285437,AHNAK
regulation of type I interferon production (GO:0032479),1/89,0.3967302263993966,0.44276432439932656,0,0,2.0088271103896105,1.8571581721285437,PRKDC
second-messenger-mediated signaling (GO:0019932),1/89,0.3967302263993966,0.44276432439932656,0,0,2.0088271103896105,1.8571581721285437,CXCR4
protein import (GO:0017038),1/89,0.3967302263993966,0.44276432439932656,0,0,2.0088271103896105,1.8571581721285437,NUP214
negative regulation of translation (GO:0017148),1/90,0.40015392975446173,0.44564511334760054,0,0,1.98615569823435,1.8191318842307858,BTG2
positive regulation of autophagy (GO:0010508),1/90,0.40015392975446173,0.44564511334760054,0,0,1.98615569823435,1.8191318842307858,HMGB1
positive regulation of transport (GO:0051050),1/91,0.4035583737403431,0.4489639951811598,0,0,1.9639880952380953,1.782189834884555,DYNC1H1
positive regulation of DNA-binding transcription factor activity (GO:0051091),2/246,0.4058816332568978,0.4510743361195356,0,0,1.45052429478659,1.3079286264140846,UBC;PPIA
regulation of endothelial cell proliferation (GO:0001936),1/92,0.40694366566553897,0.4513064971427046,0,0,1.9423076923076923,1.7462910036249044,HMGB2
regulation of lipid metabolic process (GO:0019216),1/92,0.40694366566553897,0.4513064971427046,0,0,1.9423076923076923,1.7462910036249044,MACROH2A1
regulation of epithelial cell proliferation (GO:0050678),1/93,0.4103099123258195,0.45456323271279264,0,0,1.921098602484472,1.7113963223160602,PRKDC
negative regulation of cell death (GO:0060548),1/94,0.4136572199521785,0.4568364704691074,0,0,1.9003456221198156,1.6774685632988202,SOX4
negative regulation of cellular protein metabolic process (GO:0032269),1/94,0.4136572199521785,0.4568364704691074,0,0,1.9003456221198156,1.6774685632988202,BTG2
interleukin-1-mediated signaling pathway (GO:0070498),1/94,0.4136572199521785,0.4568364704691074,0,0,1.9003456221198156,1.6774685632988202,UBC
regulation of canonical Wnt signaling pathway (GO:0060828),2/253,0.41963191302899944,0.46287773572389923,0,0,1.409568931481282,1.224037732679229,TMEM131L;SOX4
cellular protein metabolic process (GO:0044267),3/417,0.42000248232036225,0.46287773572389923,0,0,1.282806324110672,1.112827632690624,RPS27;RPL21;PRKDC
regulation of MAP kinase activity (GO:0043405),1/97,0.42358656159272895,0.46634191692518967,0,0,1.8406808035714286,1.5811400061709446,FGFR1
antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),1/98,0.4268591632115185,0.4694563354238946,0,0,1.8216126656848306,1.5507409547900919,DYNC1H1
response to UV (GO:0009411),1/99,0.4301133480725904,0.4720538612663907,0,0,1.8029336734693877,1.5211468681411058,USP1
positive regulation of stress-activated MAPK cascade (GO:0032874),1/99,0.4301133480725904,0.4720538612663907,0,0,1.8029336734693877,1.5211468681411058,HMGB1
organelle assembly (GO:0070925),3/425,0.4320237073343853,0.47365915270443487,0,0,1.2579707022834985,1.0557831273713163,DYNC1H1;CENPF;CSDE1
antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),1/100,0.43334921883721866,0.4746205730121919,0,0,1.7846320346320346,1.4923295915180979,DYNC1H1
cellular component assembly (GO:0022607),2/261,0.4351496459503874,0.4760996126323783,0,0,1.3654735816897978,1.13616317634254,SPTBN1;ACTG1
positive regulation of cell cycle process (GO:0090068),1/101,0.43656687757887847,0.4771567732215428,0,0,1.7666964285714286,1.4642622076265737,DYNC1H1
regulation of cell death (GO:0010941),1/102,0.43976642602899374,0.4786758011714768,0,0,1.749115983026874,1.4369189700230403,SOX4
calcium-mediated signaling (GO:0019722),1/102,0.43976642602899374,0.4786758011714768,0,0,1.749115983026874,1.4369189700230403,CXCR4
cell junction assembly (GO:0034329),1/102,0.43976642602899374,0.4786758011714768,0,0,1.749115983026874,1.4369189700230403,ACTG1
regulation of protein catabolic process (GO:0042176),1/102,0.43976642602899374,0.4786758011714768,0,0,1.749115983026874,1.4369189700230403,HUWE1
antigen processing and presentation of exogenous peptide antigen (GO:0002478),1/103,0.44294796512449364,0.4811488163261954,0,0,1.7318802521008403,1.4102752434506796,DYNC1H1
chromatin remodeling (GO:0006338),1/103,0.44294796512449364,0.4811488163261954,0,0,1.7318802521008403,1.4102752434506796,MYB
protein deubiquitination (GO:0016579),2/267,0.4466429947945443,0.48466491127449013,0,0,1.3341492435832059,1.0753185172485524,UBC;USP1
regulation of JNK cascade (GO:0046328),1/105,0.4492574166783162,0.4865039374059964,0,0,1.6984031593406594,1.3589929887195116,HMGB1
nucleotide-excision repair (GO:0006289),1/105,0.4492574166783162,0.4865039374059964,0,0,1.6984031593406594,1.3589929887195116,UBC
cellular response to peptide hormone stimulus (GO:0071375),1/106,0.45238552836260576,0.48789387258678585,0,0,1.6821428571428572,1.334310238316945,PRKDC
peptidyl-lysine modification (GO:0018205),1/106,0.45238552836260576,0.48789387258678585,0,0,1.6821428571428572,1.334310238316945,NUP214
regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),1/106,0.45238552836260576,0.48789387258678585,0,0,1.6821428571428572,1.334310238316945,FGFR1
small GTPase mediated signal transduction (GO:0007264),1/106,0.45238552836260576,0.48789387258678585,0,0,1.6821428571428572,1.334310238316945,JUN
negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),1/108,0.4585890176972445,0.49357800683996406,0,0,1.6505340453938584,1.2867577551410967,UBC
DNA replication (GO:0006260),1/108,0.4585890176972445,0.49357800683996406,0,0,1.6505340453938584,1.2867577551410967,MCM7
positive regulation of MAPK cascade (GO:0043410),2/274,0.45988795247749104,0.49447302207437555,0,0,1.299350821409645,1.0092998569504807,HMGB1;FGFR1
protein modification by small protein removal (GO:0070646),2/276,0.46363890849965306,0.49764855520876805,0,0,1.2897349904649176,0.9913538255905742,UBC;USP1
regulation of interleukin-6 production (GO:0032675),1/110,0.46472284739722386,0.49764855520876805,0,0,1.6200851900393185,1.2414940889979604,HMGB1
regulation of protein kinase activity (GO:0045859),1/110,0.46472284739722386,0.49764855520876805,0,0,1.6200851900393185,1.2414940889979604,PPIA
response to endoplasmic reticulum stress (GO:0034976),1/110,0.46472284739722386,0.49764855520876805,0,0,1.6200851900393185,1.2414940889979604,JUN
cytokine-mediated signaling pathway (GO:0019221),4/621,0.46725363160407474,0.49985272218110316,0,0,1.1461198756932776,0.8720631985836331,SOCS2;UBC;GAB2;PPIA
regulation of Wnt signaling pathway (GO:0030111),1/111,0.46776388246514156,0.49989311883648463,0,0,1.605275974025974,1.2196752569747675,MACF1
activation of protein kinase activity (GO:0032147),1/114,0.4767846203819182,0.5079940869728796,0,0,1.5624209860935525,1.1572702558777814,PPIA
histone modification (GO:0016570),1/114,0.4767846203819182,0.5079940869728796,0,0,1.5624209860935525,1.1572702558777814,HUWE1
positive regulation of kinase activity (GO:0033674),1/114,0.4767846203819182,0.5079940869728796,0,0,1.5624209860935525,1.1572702558777814,FGFR1
positive regulation of protein metabolic process (GO:0051247),1/115,0.47975772737330347,0.5106475609265141,0,0,1.5486372180451127,1.1374338296037154,HUWE1
proteolysis (GO:0006508),2/287,0.4839960769973466,0.514641054736877,0,0,1.2392603129445234,0.8993045373415394,DPP4;ERAP2
regulation of cellular response to stress (GO:0080135),1/118,0.4885769477115959,0.5189903721675386,0,0,1.5086996336996337,1.0806186371962068,NUP214
positive regulation of epithelial cell proliferation (GO:0050679),1/123,0.502947526074319,0.533719641511163,0,0,1.4465017564402811,0.9941364466748858,HMGB2
non-canonical Wnt signaling pathway (GO:0035567),1/124,0.5057732439956629,0.5351080921474114,0,0,1.4346689895470384,0.9779662830536217,LEF1
defense response to symbiont (GO:0140546),1/124,0.5057732439956629,0.5351080921474114,0,0,1.4346689895470384,0.9779662830536217,PMAIP1
regulation of tumor necrosis factor production (GO:0032680),1/124,0.5057732439956629,0.5351080921474114,0,0,1.4346689895470384,0.9779662830536217,HMGB1
circulatory system development (GO:0072359),1/126,0.5113770005783984,0.5399569527065324,0,0,1.4115714285714285,0.9466678244528588,SOX4
phosphatidylinositol biosynthetic process (GO:0006661),1/126,0.5113770005783984,0.5399569527065324,0,0,1.4115714285714285,0.9466678244528588,SOCS2
cellular response to insulin stimulus (GO:0032869),1/129,0.5196647636925361,0.5476148605445251,0,0,1.3782784598214286,0.9021816066099595,PRKDC
muscle contraction (GO:0006936),1/129,0.5196647636925361,0.5476148605445251,0,0,1.3782784598214286,0.9021816066099595,TPM4
regulation of primary metabolic process (GO:0080090),1/130,0.5223962692062553,0.5483087825597401,0,0,1.3675249169435215,0.887973371665049,MACROH2A1
regulation of response to external stimulus (GO:0032101),1/130,0.5223962692062553,0.5483087825597401,0,0,1.3675249169435215,0.887973371665049,CXCR4
positive regulation of canonical Wnt signaling pathway (GO:0090263),1/130,0.5223962692062553,0.5483087825597401,0,0,1.3675249169435215,0.887973371665049,SOX4
Golgi organization (GO:0007030),1/130,0.5223962692062553,0.5483087825597401,0,0,1.3675249169435215,0.887973371665049,HUWE1
cellular response to metal ion (GO:0071248),1/131,0.5251123782377586,0.550613375793408,0,0,1.3569368131868131,0.8740613299953246,JUN
regulation of cell adhesion (GO:0030155),1/133,0.5304987502989232,0.5551609078301294,0,0,1.3362418831168832,0.8470940748055895,CXCR4
defense response to virus (GO:0051607),1/133,0.5304987502989232,0.5551609078301294,0,0,1.3362418831168832,0.8470940748055895,PMAIP1
protein polyubiquitination (GO:0000209),2/314,0.5319074433007163,0.5555361056388527,0,0,1.1304573804573805,0.713641673174514,UBC;HUWE1
cilium assembly (GO:0060271),2/314,0.5319074433007163,0.5555361056388527,0,0,1.1304573804573805,0.713641673174514,DYNC1H1;TUBB
protein phosphorylation (GO:0006468),3/496,0.5340501931364873,0.5572239687755459,0,0,1.0728747925502489,0.6729772893297709,PRKDC;CAMK4;FGFR1
protein localization to plasma membrane (GO:0072659),1/136,0.5384649693894263,0.5607243480452884,0,0,1.3063492063492064,0.808673054931457,SPTBN1
organic substance transport (GO:0071702),1/136,0.5384649693894263,0.5607243480452884,0,0,1.3063492063492064,0.808673054931457,CENPF
proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),2/321,0.5438322269984994,0.565756633396669,0,0,1.105255725945381,0.6732272733480291,UBC;HUWE1
negative regulation of gene expression (GO:0010629),2/322,0.5455186872079203,0.5669536061551863,0,0,1.1017454954954955,0.6676778410647004,BTG2;MACROH2A1
protein dephosphorylation (GO:0006470),1/139,0.5462971979179669,0.5672055303211079,0,0,1.2777562111801242,0.7725213529078566,DUSP6
enzyme linked receptor protein signaling pathway (GO:0007167),1/140,0.5488785523127815,0.56876935195585,0,0,1.2684994861253853,0.7609450338489959,FGFR1
protein localization to cell periphery (GO:1990778),1/140,0.5488785523127815,0.56876935195585,0,0,1.2684994861253853,0.7609450338489959,SPTBN1
positive regulation of cellular catabolic process (GO:0031331),1/141,0.5514453491660983,0.5708700385692095,0,0,1.259375,0.749595792679056,HMGB1
Ras protein signal transduction (GO:0007265),1/142,0.5539976699043424,0.5729516468805418,0,0,1.2503799392097263,0.7384678878615671,JUN
nitrogen compound transport (GO:0071705),1/143,0.5565355954109391,0.5750143163523179,0,0,1.241511569416499,0.7275557588421795,CENPF
intracellular protein transport (GO:0006886),2/336,0.5686764435691049,0.5867590615336685,0,0,1.0548093003182824,0.5953804084341708,NUP214;ARL4C
positive regulation of transferase activity (GO:0051347),1/148,0.56901209558936094,0.5867590615336685,0,0,1.1989795918367347,0.6760489441430175,FGFR1
positive regulation of hydrolase activity (GO:0051345),1/149,0.5714653241222679,0.5887150077131057,0,0,1.19081805019305,0.6663239938101005,HMGB2
cellular response to organic cyclic compound (GO:0071407),1/150,0.5739047114703305,0.590652903439309,0,0,1.1827660594439118,0.6567804175311961,H2AZ1
actin filament organization (GO:0007015),1/152,0.5787422716582965,0.5950527924338948,0,0,1.1669820245979186,0.638220167003664,TPM4
dephosphorylation (GO:0016311),1/153,0.5811405980438216,0.5969385948838477,0,0,1.1592457706766917,0.6291952000925306,DUSP6
cellular response to interleukin-1 (GO:0071347),1/155,0.5858967239735873,0.6012402851251749,0,0,1.1440746753246753,0.6116357573156603,UBC
T cell receptor signaling pathway (GO:0050852),1/158,0.5929307250110626,0.6078689021915739,0,0,1.1220427661510464,0.5864667413321993,PAG1
heart development (GO:0007507),1/164,0.6066453801211285,0.6213270204919206,0,0,1.0804119193689745,0.5400016277606234,SOX4
negative regulation of canonical Wnt signaling pathway (GO:0090090),1/165,0.6088862012131468,0.6230189563670304,0,0,1.073769599303136,0.5327227510553966,TMEM131L
cellular protein-containing complex assembly (GO:0034622),1/168,0.6155330294483669,0.6292115412138861,0,0,1.0543199315654406,0.5116263244199357,CENPF
positive regulation of protein phosphorylation (GO:0001934),2/371,0.6228303902519391,0.6360565182302622,0,0,0.953050611587197,0.45125139860411184,CCND3;PPIA
negative regulation of cellular process (GO:0048523),3/566,0.6239513142257048,0.6362489943396789,0,0,0.9360891328919748,0.44153727030816764,BTG2;H2AC6;SOX4
positive regulation of ERK1 and ERK2 cascade (GO:0070374),1/172,0.6242216031423314,0.6362489943396789,0,0,1.0294486215538847,0.48512749862443655,HMGB1
neuron differentiation (GO:0030182),1/174,0.62849262178778,0.6399857496164305,0,0,1.0174442609413707,0.4725326458058001,SOX4
positive regulation of developmental process (GO:0051094),1/177,0.6348090947518817,0.645796175237972,0,0,0.9999492694805194,0.45440790995733227,FGFR1
positive regulation of macromolecule metabolic process (GO:0010604),2/384,0.6415799957865564,0.6520572867840314,0,0,0.9200037734069147,0.4083173641473302,LEF1;ACTG1
negative regulation of Wnt signaling pathway (GO:0030178),1/191,0.6629067501471929,0.6730857405525241,0,0,0.9256109022556391,0.38053803071967574,TMEM131L
regulation of programmed cell death (GO:0043067),1/194,0.6686429924611381,0.6782591428800423,0,0,0.9110843819393042,0.36671602356955774,PMAIP1
protein localization to membrane (GO:0072657),1/195,0.6705334897074993,0.6795253181135384,0,0,0.9063420471281296,0.3622482668640627,SPTBN1
modification-dependent protein catabolic process (GO:0019941),1/201,0.6816540472104836,0.6901339540178868,0,0,0.8788839285714286,0.3368173351398673,UBC
organelle organization (GO:0006996),2/420,0.6897057858636609,0.697618280538961,0,0,0.8392172076382602,0.3117609428161217,HUWE1;PPIA
cellular protein modification process (GO:0006464),5/1025,0.6935008252483836,0.7007868893149856,0,0,0.8563453159041394,0.31342482556444967,SOCS2;PRKDC;CAMK4;DUSP6;FGFR1
"transcription, DNA-templated (GO:0006351)",1/221,0.7161034412449424,0.7229364893484247,0,0,0.7981737012987012,0.2665346640400911,DEK
nervous system development (GO:0007399),2/447,0.7222494104209931,0.7284460211872361,0,0,0.7872051827108006,0.2561445662549084,MBNL1;CXCR4
regulation of autophagy (GO:0010506),1/231,0.7319155509806655,0.7374920504167087,0,0,0.763082298136646,0.23815046063806744,HMGB1
anterograde trans-synaptic signaling (GO:0098916),1/244,0.7511728885590228,0.7561759430023275,0,0,0.7217813051146384,0.20651566468550558,CAMK4
positive regulation of signal transduction (GO:0009967),1/252,0.7623353050563964,0.7666832250472123,0,0,0.6984917472965282,0.18954885833247961,MACF1
protein-containing complex assembly (GO:0065003),1/267,0.7819438033169522,0.7856567368559692,0,0,0.6585996240601504,0.16199733266205418,LEF1
chemical synaptic transmission (GO:0007268),1/306,0.8257371620027006,0.8288708893727299,0,0,0.5732435597189696,0.10976396708628618,CAMK4
transcription by RNA polymerase II (GO:0006366),1/320,0.8392294052920496,0.8416158396198942,0,0,0.5476936856247201,0.09599492011495002,DEK
cellular protein localization (GO:0034613),1/329,0.8473507655453634,0.8489555965407145,0,0,0.5324205139372822,0.08819042307811108,ARL4C
post-translational protein modification (GO:0043687),1/345,0.860797240691382,0.8616116184025374,0,0,0.5072414867109635,0.0760336195770983,SOCS2
ubiquitin-dependent protein catabolic process (GO:0006511),1/354,0.8678378236086712,0.8678378236086712,0,0,0.49408134358559286,0.07003623843132212,HUWE1
